LUBRIZOL CORPORATION 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2007
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 1-5263
THE LUBRIZOL CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
Ohio
|
|
34-0367600 |
(State or other jurisdiction of
|
|
(I.R.S.Employer |
incorporation or organization)
|
|
Identification No.) |
29400 Lakeland Boulevard
Wickliffe, Ohio 44092-2298
(Address of principal executive offices)
(Zip Code)
(440) 943-4200
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes
þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in
Rule 12b-2 of the Exchange Act (Check one):
Large accelerated filer þ Accelerated filer o Non-accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes o No þ
Number of the registrants common shares, without par value, outstanding as of September 30, 2007:
68,587,544.
EXPLANATORY NOTE
On October 22, 2007, we concluded to restate our previously issued financial statements because of
reporting errors relating to five postemployment employee benefit plans in three foreign countries.
Accordingly, we restated our previously issued financial statements included in our most recently
filed annual report on Form 10-K/A for the year ended December 31, 2006 and our previously issued interim financial
statements included in our most recently filed quarterly reports on Form 10-Q/A for the quarters ended March 31, 2007
and June 30, 2007. The impacts of the restatement have been reflected in this quarterly report on
Form 10-Q for the three and nine months ended September 30, 2006
in the following items:
Part
I - Item 1. Financial Statements
Part I - Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Part I - Item 4. Controls and Procedures
The impact of the restatement decreased net income for the three and nine months ended September
30, 2006 by $0.7 million or 1.4% and $1.7 million or 2.0%, respectively, from amounts previously
reported. For the three and nine months ended September 30, 2006, the impact of the restatement
decreased income from continuing operations by $0.7 million or 1.4% and $1.7 million or 1.1%,
respectively, from amounts previously reported. The restatement had no effect on our previously
reported revenues or net cash flows.
The errors primarily arose in three different postemployment employee benefit plans at a wholly
owned subsidiary and postemployment employee benefit plans at two of our consolidated joint
ventures. Four of these postemployment employee benefit plans had been accounted for
inappropriately on a cash basis rather than an accrual basis as required by U.S. generally accepted
accounting principles (U.S. GAAP), while the accrual recorded in the financial statements for the
fifth plan was not calculated in accordance with U.S. GAAP.
See
Item 2 - Managements Discussion and Analysis of Financial Condition and Results of
Operations and Note 16 - Restatement of Consolidated Financial Statements contained in the Notes
to Financial Statements for more information regarding the restatement and changes to previously
issued financial statements.
-2-
THE LUBRIZOL CORPORATION
Quarterly Report on Form 10-Q
Quarter Ended September 30, 2007
Table of Contents
-3-
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
THE LUBRIZOL CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
(In Millions of Dollars Except Per Share Data) |
|
2007 |
|
|
2006 |
|
2007 |
|
|
2006 |
|
|
|
|
|
|
(as restated, |
|
|
|
|
|
(as restated, |
|
|
|
|
|
|
see Note 16) |
|
|
|
|
|
see Note 16) |
Net sales |
|
$ |
1,120.4 |
|
|
|
$ |
1,029.9 |
|
|
$ |
3,349.7 |
|
|
|
$ |
3,053.2 |
|
Royalties and other revenues |
|
|
1.0 |
|
|
|
|
1.1 |
|
|
|
3.0 |
|
|
|
|
3.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
1,121.4 |
|
|
|
|
1,031.0 |
|
|
|
3,352.7 |
|
|
|
|
3,056.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
846.0 |
|
|
|
|
782.8 |
|
|
|
2,503.0 |
|
|
|
|
2,297.4 |
|
Selling and administrative expenses |
|
|
103.7 |
|
|
|
|
101.7 |
|
|
|
309.4 |
|
|
|
|
280.6 |
|
Research, testing and development expenses |
|
|
56.0 |
|
|
|
|
50.5 |
|
|
|
161.4 |
|
|
|
|
152.8 |
|
Amortization of intangible assets |
|
|
5.8 |
|
|
|
|
5.9 |
|
|
|
17.7 |
|
|
|
|
17.7 |
|
Restructuring and impairment charges |
|
|
2.1 |
|
|
|
|
2.7 |
|
|
|
0.6 |
|
|
|
|
6.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
1,013.6 |
|
|
|
|
943.6 |
|
|
|
2,992.1 |
|
|
|
|
2,754.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) net |
|
|
5.5 |
|
|
|
|
1.6 |
|
|
|
9.7 |
|
|
|
|
(0.1 |
) |
Interest income |
|
|
6.9 |
|
|
|
|
7.6 |
|
|
|
20.9 |
|
|
|
|
13.5 |
|
Interest expense |
|
|
(21.7 |
) |
|
|
|
(25.0 |
) |
|
|
(70.3 |
) |
|
|
|
(75.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before
income taxes |
|
|
98.5 |
|
|
|
|
71.6 |
|
|
|
320.9 |
|
|
|
|
239.8 |
|
Provision for income taxes |
|
|
27.1 |
|
|
|
|
21.5 |
|
|
|
97.2 |
|
|
|
|
81.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
71.4 |
|
|
|
|
50.1 |
|
|
|
223.7 |
|
|
|
|
158.4 |
|
Discontinued operations net of tax |
|
|
|
|
|
|
|
(0.5 |
) |
|
|
|
|
|
|
|
(73.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
71.4 |
|
|
|
$ |
49.6 |
|
|
$ |
223.7 |
|
|
|
$ |
84.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
1.03 |
|
|
|
$ |
0.73 |
|
|
$ |
3.23 |
|
|
|
$ |
2.31 |
|
Discontinued operations |
|
|
|
|
|
|
|
(0.01 |
) |
|
|
|
|
|
|
|
(1.07 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, basic |
|
$ |
1.03 |
|
|
|
$ |
0.72 |
|
|
$ |
3.23 |
|
|
|
$ |
1.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
1.02 |
|
|
|
$ |
0.72 |
|
|
$ |
3.19 |
|
|
|
$ |
2.29 |
|
Discontinued operations |
|
|
|
|
|
|
|
(0.01 |
) |
|
|
|
|
|
|
|
(1.06 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, diluted |
|
$ |
1.02 |
|
|
|
$ |
0.71 |
|
|
$ |
3.19 |
|
|
|
$ |
1.23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid per share |
|
$ |
0.30 |
|
|
|
$ |
0.26 |
|
|
$ |
0.86 |
|
|
|
$ |
0.78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-4-
THE LUBRIZOL CORPORATION
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
(In Millions of Dollars Except Share Data) |
|
2007 |
|
2006 |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments |
|
|
$ |
646.0 |
|
|
|
$ |
575.7 |
|
Receivables |
|
|
|
655.3 |
|
|
|
|
573.6 |
|
Inventories |
|
|
|
571.5 |
|
|
|
|
589.0 |
|
Other current assets |
|
|
|
78.2 |
|
|
|
|
98.0 |
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
|
1,951.0 |
|
|
|
|
1,836.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment at cost |
|
|
|
2,696.6 |
|
|
|
|
2,546.0 |
|
Less accumulated depreciation |
|
|
|
1,571.7 |
|
|
|
|
1,464.7 |
|
|
|
|
|
|
|
|
|
|
Property and equipment net |
|
|
|
1,124.9 |
|
|
|
|
1,081.3 |
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
1,113.5 |
|
|
|
|
1,076.1 |
|
Intangible assets net |
|
|
|
320.7 |
|
|
|
|
322.8 |
|
Investments in non-consolidated companies |
|
|
|
7.3 |
|
|
|
|
7.7 |
|
Other assets |
|
|
|
73.1 |
|
|
|
|
66.7 |
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
|
$ |
4,590.5 |
|
|
|
$ |
4,390.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
Short-term debt and current portion of long-term debt |
|
|
$ |
3.5 |
|
|
|
$ |
3.7 |
|
Accounts payable |
|
|
|
392.4 |
|
|
|
|
340.5 |
|
Accrued expenses and other current liabilities |
|
|
|
290.6 |
|
|
|
|
290.2 |
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
|
686.5 |
|
|
|
|
634.4 |
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
|
1,428.8 |
|
|
|
|
1,538.0 |
|
Pension obligations |
|
|
|
232.2 |
|
|
|
|
237.9 |
|
Other postretirement benefit obligations |
|
|
|
97.2 |
|
|
|
|
93.5 |
|
Noncurrent liabilities |
|
|
|
141.9 |
|
|
|
|
72.3 |
|
Deferred income taxes |
|
|
|
78.1 |
|
|
|
|
80.4 |
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
|
2,664.7 |
|
|
|
|
2,656.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest in consolidated companies |
|
|
|
58.1 |
|
|
|
|
51.3 |
|
|
|
|
|
|
|
|
|
|
Contingencies and commitments |
|
|
|
|
|
|
|
|
|
|
Shareholders equity: |
|
|
|
|
|
|
|
|
|
|
Preferred stock without par value authorized and unissued: |
|
|
|
|
|
|
|
|
|
|
Serial preferred stock 2,000,000 shares |
|
|
|
|
|
|
|
|
|
|
Serial preference shares 25,000,000 shares |
|
|
|
|
|
|
|
|
|
|
Common shares without par value: |
|
|
|
|
|
|
|
|
|
|
Authorized 120,000,000 shares |
|
|
|
|
|
|
|
|
|
|
Outstanding 68,587,544 shares as of September 30, 2007 after deducting
17,608,350 treasury shares; 69,020,569 shares as of December 31, 2006
after deducting 17,175,325 treasury shares |
|
|
|
756.3 |
|
|
|
|
710.1 |
|
Retained earnings |
|
|
|
1,107.1 |
|
|
|
|
1,033.8 |
|
Accumulated other comprehensive income (loss) |
|
|
|
4.3 |
|
|
|
|
(60.8 |
) |
|
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
|
1,867.7 |
|
|
|
|
1,683.1 |
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
|
$ |
4,590.5 |
|
|
|
$ |
4,390.9 |
|
|
|
|
|
|
|
|
|
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-5-
THE LUBRIZOL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
September 30, |
(In Millions of Dollars) |
|
2007 |
|
|
|
2006 |
|
|
|
|
|
|
|
(as restated, see |
|
|
|
|
|
|
Note 16) |
CASH PROVIDED BY (USED FOR): |
|
|
|
|
|
|
|
|
|
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
|
Net income |
|
|
$ 223.7 |
|
|
|
|
$ 84.8 |
|
Adjustments to reconcile net income to cash provided by
operating activities: |
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
117.9 |
|
|
|
|
120.8 |
|
Deferred income taxes |
|
|
10.9 |
|
|
|
|
32.2 |
|
Deferred compensation |
|
|
16.0 |
|
|
|
|
12.9 |
|
Restructuring and impairment charges |
|
|
2.8 |
|
|
|
|
61.6 |
|
(Gain) loss from divestitures and sales of property and equipment |
|
|
(8.0 |
) |
|
|
|
5.2 |
|
Change in current assets and liabilities, net of acquisitions and
divestitures: |
|
|
|
|
|
|
|
|
|
Receivables |
|
|
(46.1 |
) |
|
|
|
(45.0 |
) |
Inventories |
|
|
33.7 |
|
|
|
|
(28.8 |
) |
Accounts payable, accrued expenses and other current liabilities |
|
|
50.3 |
|
|
|
|
(24.1 |
) |
Other current assets |
|
|
8.1 |
|
|
|
|
9.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46.0 |
|
|
|
|
(88.4 |
) |
Change in noncurrent liabilities |
|
|
(1.9 |
) |
|
|
|
5.5 |
|
Other items net |
|
|
(0.9 |
) |
|
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
Total operating activities |
|
|
406.5 |
|
|
|
|
245.1 |
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(121.6 |
) |
|
|
|
(91.2 |
) |
Acquisitions |
|
|
(15.7 |
) |
|
|
|
|
|
Net proceeds from divestitures and sales of property and equipment |
|
|
12.9 |
|
|
|
|
281.4 |
|
Other items net |
|
|
(1.3 |
) |
|
|
|
(0.8 |
) |
|
|
|
|
|
|
|
|
|
|
Total investing activities |
|
|
(125.7 |
) |
|
|
|
189.4 |
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
|
Changes in short-term debt net |
|
|
(0.4 |
) |
|
|
|
4.5 |
|
Repayments of long-term debt |
|
|
(113.7 |
) |
|
|
|
(114.3 |
) |
Dividends paid |
|
|
(59.4 |
) |
|
|
|
(53.3 |
) |
Common shares purchased |
|
|
(82.1 |
) |
|
|
|
|
|
Proceeds from the exercise of stock options |
|
|
34.5 |
|
|
|
|
17.9 |
|
|
|
|
|
|
|
|
|
|
|
Total financing activities |
|
|
(221.1 |
) |
|
|
|
(145.2 |
) |
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
10.6 |
|
|
|
|
8.0 |
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and short-term investments |
|
|
70.3 |
|
|
|
|
297.3 |
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments at the beginning of period |
|
|
575.7 |
|
|
|
|
262.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments at the end of period |
|
|
$ 646.0 |
|
|
|
|
$ 559.7 |
|
|
|
|
|
|
|
|
|
|
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-6-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
(In Millions of Dollars except Share and Per Share Data)
1. Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with
generally accepted accounting principles for interim financial information and Article 10 of
Regulation S-X. Accordingly, they do not include all of the information and footnotes required by
U.S. generally accepted accounting principles (U.S. GAAP) for complete financial statements. In
the opinion of management, all adjustments (consisting of normal recurring accruals unless
otherwise noted) considered necessary for a fair presentation have been included. Operating
results for the nine months ended September 30, 2007 are not necessarily indicative of the results
that may be expected for the year ending December 31, 2007.
The balance sheet at December 31, 2006 has been derived from the audited financial statements at
that date but does not include all of the information and footnotes required by U.S. GAAP for
complete financial statements.
2. Significant Accounting Policies
Net Income Per Share
Net income per share is computed by dividing net income by the weighted-average common shares
outstanding during the period, including contingently issuable shares. Net income per diluted
share includes the dilutive effect resulting from outstanding stock options and awards. Per share
amounts from continuing operations are computed as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
71.4 |
|
|
$ |
50.1 |
|
|
$ |
223.7 |
|
|
$ |
158.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator (in millions): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
69.2 |
|
|
|
68.7 |
|
|
|
69.3 |
|
|
|
68.6 |
|
Dilutive effect of stock options and awards |
|
|
0.8 |
|
|
|
0.6 |
|
|
|
0.8 |
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for income from continuing
operations
per share, diluted |
|
|
70.0 |
|
|
|
69.3 |
|
|
|
70.1 |
|
|
|
69.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations per share, basic |
|
$ |
1.03 |
|
|
$ |
0.73 |
|
|
$ |
3.23 |
|
|
$ |
2.31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations per share,
diluted |
|
$ |
1.02 |
|
|
$ |
0.72 |
|
|
$ |
3.19 |
|
|
$ |
2.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares issuable upon the exercise of stock options and awards that were excluded
from the diluted earnings per share calculations because they were antidilutive were less than 0.1
million for the three and nine months ended September 30, 2007 and 2006, respectively.
-7-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
New Accounting Standards
In February 2007, the Financial Accounting Standards Board (FASB) issued Statement of Financial
Accounting Standards (SFAS) No. 159, The Fair Value Option for Financial Assets and Financial
Liabilities. This statement permits entities to make an irrevocable election to measure many
financial instruments and certain other items at fair value at specified election dates. The fair
value option may be applied instrument by instrument and must be applied to entire instruments.
Unrealized gains and losses on items for which the entity elects the fair value option are reported
in earnings. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. Early
adoption is permitted as of the beginning of the fiscal year that begins on or before November 15,
2007, provided the entity also elects to apply the provisions of SFAS No. 157, Fair Value
Measurements. Entities are not permitted to apply this statement retrospectively to the fiscal
years preceding the effective date unless the entity chooses early adoption. The company currently
is evaluating the impact of this recently issued standard on its consolidated financial statements.
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements. This statement defines
fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP and
expands disclosure about fair value measurements. SFAS No. 157 does not expand the use of fair
value measures in financial statements, but simplifies and codifies related guidance within U.S.
GAAP. SFAS No. 157 establishes a fair value hierarchy from observable market data as the highest
level to fair value based on an entitys own fair value assumptions as the lowest level. SFAS No.
157 is effective for fiscal years beginning after November 15, 2007 and interim periods within
those years. SFAS No. 157 requires adoption prospectively as of the beginning of the fiscal year
in which this statement is initially applied, with the exception of certain financial instruments
in which adoption is applied retrospectively as of the beginning of the fiscal year in which this
statement is initially applied. The company currently is evaluating the impact of this recently
issued standard on its consolidated financial statements.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates.
Reclassifications
Certain prior period amounts have been reclassified to conform to the current period presentation.
3. Stock-Based Compensation
The company utilizes the 2005 Stock Incentive Plan (2005 Plan) and other deferred compensation
plans to provide equity awards to its key employees. The 2005 Plan, approved by the companys
shareholders on April 25, 2005, provides for the granting of stock appreciation rights, restricted
and unrestricted shares and options to buy common shares up to an amount equal to 4,000,000 common
shares, of which no more than 2,000,000 can be settled as full-value awards. After the 2,000,000
limit has been reached, full-value awards are counted in a 3-to-1 ratio against the 4,000,000
limit. Options become exercisable 50% one year after date of grant, 75% after two years, 100%
after three years and expire up to 10 years after grant. In addition, the 2005 Plan provides each
nonemployee director of the company an automatic annual grant of restricted stock units worth
approximately $0.1 million based on the fair market value of the companys common shares on the
date of each Annual Meeting of Shareholders. These restricted stock units vest one year after the
grant date.
-8-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
The fair value of share-based payment awards are estimated using the Black-Scholes option pricing
model. There were 213,200 stock options granted during the nine months ended September 30, 2007.
There were no stock options granted during the nine months ended September 30, 2006. The
weighted-average assumptions used to value the options granted during the first nine months of 2007
were as follows:
|
|
|
|
|
Risk-free interest rate |
|
|
4.8 |
% |
Dividend yield |
|
|
2.0 |
% |
Volatility |
|
|
17.8 |
% |
Expected life (years) |
|
|
10.0 |
|
Weighted-average fair value of
options granted during the period |
|
$ |
14.68 |
|
The
company issued 39,288 and 877,421 common shares from treasury upon exercise of employee stock options
during the three and nine months ended September 30, 2007,
respectively. The company issued 214,639
and 560,663 common shares from treasury upon exercise of employee stock options during the three and
nine months ended September 30, 2006, respectively. Cash received from option exercises during the
nine months ended September 30, 2007 was $26.0 million. The company realized a reduction in its
income tax payable of $8.5 million for the nine months ended September 30, 2007 relating to the
exercise of nonqualified stock options. For accounting purposes, these tax benefits were realized
as increases in paid-in capital included in the common shares caption in shareholders equity (see
Note 14).
As of September 30, 2007, there was $18.6 million of total before-tax unrecognized compensation
cost related to nonvested stock-based awards. That cost is expected to be recognized over a
weighted-average period of 1.8 years. The company is using previously purchased treasury shares
for all net shares issued for option exercises, long-term incentive plans and restricted stock
awards.
Under the companys long-term incentive program, dollar-based target awards are determined by the
organization and compensation committee of the board of directors for three-year performance
periods. During the nine months ended September 30, 2007, the award for the 2004-2006 performance
period was paid resulting in the issuance of 178,541 shares in lieu of a cash distribution. In
addition, during the nine months ended September 30, 2006, the award for the 2003-2005 performance
period was paid in cash.
The following table identifies the number of shares expected to be issued based on current
performance measures and the stock price on the date of grant for the performance shares granted:
|
|
|
|
|
|
|
|
|
|
|
Expected |
|
Average |
|
|
Number of Units |
|
Stock Price on |
Award |
|
to be Issued |
|
Date of Grant |
2005-2007 |
|
|
230,515 |
|
|
$ |
39.44 |
|
2006-2008 |
|
|
290,346 |
|
|
$ |
43.07 |
|
2007-2009 |
|
|
219,368 |
|
|
$ |
53.07 |
|
-9-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
Performance-based stock awards as of September 30, 2007 and changes during the nine months ended
September 30, 2007 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted- |
|
|
|
|
|
|
Average |
|
|
Share |
|
|
Grant Date |
|
|
Units |
|
|
Fair Value |
Nonvested at January 1, 2007 |
|
|
370,448 |
|
|
$ |
40.95 |
|
Granted |
|
|
129,930 |
|
|
$ |
53.07 |
|
Performance increase |
|
|
250,722 |
|
|
$ |
46.45 |
|
Vested |
|
|
|
|
|
|
|
|
Forfeited |
|
|
(10,871 |
) |
|
$ |
43.55 |
|
|
|
|
|
|
|
|
|
Nonvested at September 30, 2007 |
|
|
740,229 |
|
|
$ |
44.90 |
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense recognized in the consolidated statements of income for
the three and nine months ended September 30, 2007 was $3.7
million and $15.4 million,
respectively, compared to $4.2 million and $9.7 million, respectively, for the same periods in
2006. The related tax benefit for the three and nine months ended
September 30, 2007 was $1.3
million and $5.4 million, respectively, compared to $1.5 million
and $3.4 million for the three
and nine months ended September 30, 2006, respectively.
In prior years, certain international employees received stock-based awards that are similar to
stock appreciation rights. These awards vested 50% one year after grant, 75% two years after
grant and 100% three years after grant and have a 10-year exercise period from the date of
grant. The value of these awards is based on Lubrizol common shares and is paid in cash upon
employee exercise. At September 30, 2007, the portion of these fully vested stock-based awards
that remained unexercised are accounted for using variable accounting. Compensation expense
recognized in the consolidated statements of income for the three and nine months ended
September 30, 2007 was $0.1 million and $2.8 million, respectively, compared to compensation
credits of $1.5 million and $0.6 million, respectively, for the same periods in 2006.
The three
and nine months ended September 30, 2006 also includes
compensation expense of $1.3
million and $3.2 million, respectively, related to the cash portion
of the 2003-2005 and 2004-2006 performance periods under the companys long-term incentive
program.
4. Acquisitions
On November 1, 2007, the company completed the acquisition of the refrigeration lubricants business
of Croda International Plc (Croda) for approximately $124.1 million.
The acquisition primarily includes
lubricant technology, trade names, customer lists, manufacturing
know-how and inventory. No manufacturing facilities are included in the transaction. Annualized
revenues for this business are approximately $84.0 million.
On February 7, 2007, the company completed the acquisition of the entire metalworking additives
product line of Lockhart Chemical Company (Lockhart), a private company with headquarters in
Gibsonia, Pennsylvania, for approximately $15.7 million. Annualized revenues of these products are
approximately $20.0 million. The
company began including the results of the acquired products in the Lubrizol Additives segment in
February 2007. The purchase price for this acquisition included goodwill of $8.1 million.
5. Divestitures
-10-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
In May 2006, the company sold the food ingredients and industrial specialties business (FIIS) and
the active pharmaceutical ingredients and intermediate compounds business (A&I), both of which were
included in the Lubrizol Advanced Materials segment. The results of these divested businesses have
been reflected in the discontinued operations - net of tax line item in the companys consolidated
statements of income for the three and nine months ended September 30, 2006.
In February 2006, the company sold certain assets and liabilities of its Telene® resins
business (Telene), which was included in the Lubrizol Advanced Materials segment. The results of
Telene have been reflected in the discontinued operations - net of tax line item in the companys
consolidated statements of income for the nine months ended September 30, 2006.
Total revenues from discontinued operations for the nine months ended September 30, 2006 were
$143.8 million. Net loss from discontinued operations for the three and nine months ended
September 30, 2006 was $0.5 million or $0.01 per diluted share and $73.6 million or $1.06 per
diluted share, respectively.
6. Inventories
The companys inventories were comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
|
|
2007 |
|
2006 |
Finished products |
|
|
$ |
323.9 |
|
|
|
$ |
315.0 |
|
Products in process |
|
|
|
93.6 |
|
|
|
|
108.2 |
|
Raw materials |
|
|
|
123.5 |
|
|
|
|
138.2 |
|
Supplies and engine test parts |
|
|
|
30.5 |
|
|
|
|
27.6 |
|
|
|
|
|
|
|
|
|
|
Total inventory |
|
|
$ |
571.5 |
|
|
|
$ |
589.0 |
|
|
|
|
|
|
|
|
|
|
7. Goodwill and Intangible Assets
Goodwill is tested for impairment at the reporting unit level as of October 1 each year or if
events or circumstances occur that would more likely than not reduce the fair value of a reporting
unit below its carrying amount.
The carrying amount of goodwill by reportable segment as of September 30, 2007 follows:
-11-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol |
|
|
|
|
|
|
|
|
|
|
|
|
|
Advanced |
|
|
|
Lubrizol |
|
|
|
|
|
|
|
Materials |
|
|
|
Additives |
|
|
Total |
|
Balance, January 1, 2007 |
|
|
$ |
978.3 |
|
|
|
|
$ |
97.8 |
|
|
|
$ |
1,076.1 |
|
Additions |
|
|
|
|
|
|
|
|
|
8.1 |
|
|
|
|
8.1 |
|
Translation and other adjustments |
|
|
|
28.0 |
|
|
|
|
|
1.3 |
|
|
|
|
29.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2007 |
|
|
$ |
1,006.3 |
|
|
|
|
$ |
107.2 |
|
|
|
$ |
1,113.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table shows the components of identifiable intangible assets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2007 |
|
|
December 31, 2006 |
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Carrying |
|
Accumulated |
|
Carrying |
|
Accumulated |
|
|
Amount |
|
Amortization |
|
Amount |
|
Amortization |
Amortized intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer lists |
|
|
$ |
152.6 |
|
|
|
$ |
31.5 |
|
|
|
$ |
145.0 |
|
|
|
$ |
24.0 |
|
Technology |
|
|
|
141.5 |
|
|
|
|
52.5 |
|
|
|
|
139.8 |
|
|
|
|
44.9 |
|
Trademarks |
|
|
|
23.0 |
|
|
|
|
6.8 |
|
|
|
|
20.7 |
|
|
|
|
5.5 |
|
Patents |
|
|
|
14.5 |
|
|
|
|
5.4 |
|
|
|
|
14.0 |
|
|
|
|
4.2 |
|
Land-use rights |
|
|
|
9.0 |
|
|
|
|
1.4 |
|
|
|
|
7.5 |
|
|
|
|
1.2 |
|
Non-compete agreements |
|
|
|
1.4 |
|
|
|
|
1.0 |
|
|
|
|
8.2 |
|
|
|
|
7.2 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.9 |
|
|
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortized intangible assets |
|
|
|
342.0 |
|
|
|
|
98.6 |
|
|
|
|
336.1 |
|
|
|
|
87.7 |
|
Non-amortized trademarks |
|
|
|
77.3 |
|
|
|
|
|
|
|
|
|
74.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
$ |
419.3 |
|
|
|
$ |
98.6 |
|
|
|
$ |
410.5 |
|
|
|
$ |
87.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Definite-lived intangible assets are amortized over their useful lives, which range between 3 and
40 years. The companys indefinite-lived intangible assets consist of certain trademarks that are
tested for impairment each year as of October 1 or more frequently if impairment indicators arise.
Indefinite-lived trademarks are assessed for impairment separately from goodwill. Annual
intangible amortization expense for the next five years will approximate $23.5 million in 2007,
$22.1 million in 2008, $20.3 million in 2009 and $20.2 million in each of 2010 and 2011.
8. Income Taxes
Effective January 1, 2007, the company adopted the provisions of FASB Interpretation (FIN) No. 48
Accounting for Uncertainty in Income Taxes. FIN No. 48 prescribes a recognition threshold and
measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in tax returns. Under FIN No. 48, the economic benefit associated
with a tax position only will be recognized if it is more likely than not that a tax position
ultimately will be sustained. After this threshold is met, a tax position is reported at the
largest amount of benefit that is more likely than not to be ultimately sustained. FIN No. 48 also
provides guidance on derecognition, classification, interest and penalties, accounting in interim
periods and disclosure. Prior to
January 1, 2007, the company regularly assessed positions with regard to tax exposures and recorded
liabilities for uncertain income tax positions in accordance with SFAS No. 5, Accounting for
Contingencies.
-12-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
As a result of adopting FIN No. 48 on January 1, 2007, the company recognized an $8.9 million
reduction to retained earnings and a $5.4 million increase to goodwill for pre-acquisition income
tax liabilities of Noveon International, Inc. (Noveon International). As of January 1, 2007, after
recording this FIN No. 48 adoption impact, the company had gross unrecognized tax benefits of $57.8
million, of which $38.8 million, if recognized, would affect the effective tax rate.
The company recognizes accrued interest and penalties related to unrecognized tax benefits as a
component of the income tax provision. As of January 1, 2007, the date of adoption, the company
had accrued interest of $7.1 million. Penalties were immaterial to the companys consolidated
financial statements.
The company operates in numerous taxing jurisdictions and is subject to regular examinations by
various U.S. federal, state and foreign jurisdictions. The companys income tax positions are
based on research and interpretations of the income tax laws and rulings in each of the
jurisdictions in which the company does business. Due to the subjectivity of interpretations of
laws and rulings in each jurisdiction, the differences and interplay in tax laws between those
jurisdictions and difficulty in estimating the final resolution of complex tax audit matters, the
companys estimates of income tax liabilities may differ from actual payments or assessments.
It is reasonably possible that unrecognized tax benefits may decrease by up to $6.3 million within
12 months of September 30, 2007 primarily as a result of the settlement of foreign audits and the
closure of statutes of limitations.
With few exceptions, the company is no longer subject to U.S. federal, state and local tax
examinations for years before 2001 and foreign jurisdiction examinations for years before 2000.
Effective with the adoption of FIN No. 48, the majority of the companys unrecognized tax benefits
are classified as noncurrent liabilities because payment of cash is not expected within one year.
Prior to the adoption of FIN No. 48, the company classified unrecognized tax benefits in accrued
expenses and other current liabilities.
9. Comprehensive Income
Total comprehensive income was comprised of the following:
-13-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
September 30, |
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
Net income |
|
|
$ |
71.4 |
|
|
|
$ |
49.6 |
|
|
|
$ |
223.7 |
|
|
|
$ |
84.8 |
|
Foreign currency translation adjustment |
|
|
|
40.4 |
|
|
|
|
10.5 |
|
|
|
|
60.7 |
|
|
|
|
48.2 |
|
Pension and other postretirement benefit plans |
|
|
|
1.6 |
|
|
|
|
|
|
|
|
|
1.6 |
|
|
|
|
(0.8 |
) |
Unrealized (loss) gain natural gas hedges |
|
|
|
(0.3 |
) |
|
|
|
0.2 |
|
|
|
|
0.5 |
|
|
|
|
(0.6 |
) |
Amortization of treasury rate locks |
|
|
|
0.8 |
|
|
|
|
0.9 |
|
|
|
|
2.3 |
|
|
|
|
2.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
$ |
113.9 |
|
|
|
$ |
61.2 |
|
|
|
$ |
288.8 |
|
|
|
$ |
134.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10. Segment Reporting
The company is organized into two operating and reportable segments. The company changed the
names of its two reportable segments in 2007. The new segment names are Lubrizol Additives,
previously known as Lubricant Additives, and Lubrizol Advanced Materials, previously known as
Specialty Chemicals. The change was in name only as the management structure of the segments and
product lines included in each segment remained unchanged. The Lubrizol Additives segment
represented 66% and 65% of the companys consolidated revenues for the three and nine months ended
September 30, 2007, respectively. The Lubrizol Advanced Materials segment represented 34% and 35%
of the companys consolidated revenues for the three and nine months ended September 30, 2007,
respectively.
Lubrizol Additives consists of two product lines: engine additives and driveline and industrial
oil additives. Engine additives is comprised of additives for lubricating engine oils, such as
for gasoline, diesel, marine and stationary gas engines and additive components, additives for
fuel products and refinery and oil field chemicals, as well as outsourcing strategies for supply
chain and knowledge center management. In addition, this product line sells additive components
and viscosity improvers within its lubricant and fuel additives product areas. Driveline and
industrial oil additives is comprised of additives for driveline oils, such as automatic
transmission fluids, gear oils and tractor lubricants and industrial oil additives, such as
additives for hydraulic, grease and metalworking fluids, as well as compressor lubricants.
Lubrizol Additives product lines generally are produced in company-owned shared manufacturing
facilities and largely sold to a common customer base.
The Lubrizol Advanced Materials segment consists of engineered polymers, performance coatings and
Noveon® consumer specialties product lines. The engineered polymers product line is
characterized by products such as TempRite® engineered polymers and Estane®
engineered polymers. Engineered polymers products are sold to a diverse customer base comprised
of major manufacturers in the construction, automotive, telecommunications, electronics and
recreation industries. The performance coatings product line includes high-performance polymers
and additives for specialty paper, graphic arts, paints and textiles coatings applications. The
Noveon consumer specialties product line is characterized by global production of acrylic
thickeners, specialty monomers, film formers, fixatives, emollients, silicones, surfactants and
process chemicals. The company markets products in the Noveon consumer specialties product line
to the personal care and pharmaceutical primary end-use industries. The Noveon consumer
specialties products are sold to customers worldwide and these customers include major
manufacturers of cosmetics, personal care products, water soluble polymers and household products.
During the first quarter of 2006, the company completed the sale of the Telene business. In
addition, the FIIS and A&I
businesses were sold during the second quarter of 2006. The company recorded the results of
operations of these divested businesses in the discontinued
operations - net of tax line item in
the consolidated statements of income for 2006.
-14-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
The company primarily evaluates performance and allocates resources based on segment operating
income, defined as revenues less expenses identifiable to the product lines included within each
segment, as well as projected future returns. Segment operating income reconciles to consolidated
income from continuing operations before income taxes by deducting corporate expenses and income
that are not attributed to the operating segments, restructuring and impairment charges and net
interest expense.
The following table presents a summary of the results of the companys reportable segments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
September 30, |
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
Revenues from external customers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives |
|
|
$ |
738.8 |
|
|
|
$ |
661.3 |
|
|
|
$ |
2,193.8 |
|
|
|
$ |
1,967.3 |
|
Lubrizol Advanced Materials |
|
|
|
382.6 |
|
|
|
|
369.7 |
|
|
|
|
1,158.9 |
|
|
|
|
1,088.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
$ |
1,121.4 |
|
|
|
$ |
1,031.0 |
|
|
|
$ |
3,352.7 |
|
|
|
$ |
3,056.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives |
|
|
$ |
97.0 |
|
|
|
$ |
70.6 |
|
|
|
$ |
304.3 |
|
|
|
$ |
233.4 |
|
Lubrizol Advanced Materials |
|
|
|
30.9 |
|
|
|
|
42.5 |
|
|
|
|
119.8 |
|
|
|
|
135.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total segment operating income |
|
|
|
127.9 |
|
|
|
|
113.1 |
|
|
|
|
424.1 |
|
|
|
|
368.8 |
|
|
Corporate expenses |
|
|
|
(17.7 |
) |
|
|
|
(22.0 |
) |
|
|
|
(57.0 |
) |
|
|
|
(56.2 |
) |
Corporate other income (expense) net |
|
|
|
5.2 |
|
|
|
|
0.6 |
|
|
|
|
3.8 |
|
|
|
|
(5.0 |
) |
Restructuring and impairment charges |
|
|
|
(2.1 |
) |
|
|
|
(2.7 |
) |
|
|
|
(0.6 |
) |
|
|
|
(6.3 |
) |
Interest expense net |
|
|
|
(14.8 |
) |
|
|
|
(17.4 |
) |
|
|
|
(49.4 |
) |
|
|
|
(61.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
$ |
98.5 |
|
|
|
$ |
71.6 |
|
|
|
$ |
320.9 |
|
|
|
$ |
239.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The companys total assets by segment were as follows:
-15-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
|
|
|
2007 |
|
|
2006 |
|
Segment total assets: |
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives |
|
|
|
$ 1,494.0 |
|
|
|
|
$ 1,397.6 |
|
Lubrizol Advanced Materials |
|
|
|
2,248.1 |
|
|
|
|
2,193.7 |
|
|
|
|
|
|
|
|
|
|
|
|
Total segment assets |
|
|
|
3,742.1 |
|
|
|
|
3,591.3 |
|
|
|
|
|
|
|
|
|
|
|
|
Corporate assets |
|
|
|
848.4 |
|
|
|
|
799.6 |
|
|
|
|
|
|
|
|
|
|
|
|
Total consolidated assets |
|
|
|
$ 4,590.5 |
|
|
|
|
$ 4,390.9 |
|
|
|
|
|
|
|
|
|
|
|
|
11. Pension and Postretirement Benefits
The components of net periodic pension cost and net periodic non-pension postretirement benefit
cost consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
Pension benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost - benefits earned during period |
|
|
$ |
7.9 |
|
|
|
$ |
8.3 |
|
|
|
$ |
23.4 |
|
|
|
$ |
25.0 |
|
Interest cost on projected benefit obligation |
|
|
|
10.0 |
|
|
|
|
8.7 |
|
|
|
|
29.7 |
|
|
|
|
25.7 |
|
Expected return on plan assets |
|
|
|
(8.7 |
) |
|
|
|
(7.2 |
) |
|
|
|
(25.8 |
) |
|
|
|
(21.5 |
) |
Amortization of prior service costs |
|
|
|
0.6 |
|
|
|
|
0.5 |
|
|
|
|
2.0 |
|
|
|
|
1.5 |
|
Recognized net actuarial loss |
|
|
|
1.4 |
|
|
|
|
2.2 |
|
|
|
|
3.9 |
|
|
|
|
6.4 |
|
Settlement / curtailment loss |
|
|
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
2.7 |
|
Amortization of initial net asset obligation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic pension cost |
|
|
$ |
11.2 |
|
|
|
$ |
12.9 |
|
|
|
$ |
33.2 |
|
|
|
$ |
40.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other postretirement benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost - benefits earned during period |
|
|
$ |
0.6 |
|
|
|
$ |
0.5 |
|
|
|
$ |
1.4 |
|
|
|
$ |
1.4 |
|
Interest cost on projected benefit obligation |
|
|
|
1.5 |
|
|
|
|
1.4 |
|
|
|
|
4.4 |
|
|
|
|
4.1 |
|
Amortization of prior service costs |
|
|
|
(1.9 |
) |
|
|
|
(2.1 |
) |
|
|
|
(5.1 |
) |
|
|
|
(6.3 |
) |
Recognized net actuarial loss |
|
|
|
0.4 |
|
|
|
|
0.4 |
|
|
|
|
1.0 |
|
|
|
|
1.3 |
|
Settlement / curtailment gain |
|
|
|
|
|
|
|
|
(1.1 |
) |
|
|
|
|
|
|
|
|
(1.1 |
) |
Amortization of initial net obligation |
|
|
|
0.1 |
|
|
|
|
0.1 |
|
|
|
|
0.3 |
|
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic non-pension postretirement
benefit cost |
|
|
$ |
0.7 |
|
|
|
$ |
(0.8 |
) |
|
|
$ |
2.0 |
|
|
|
$ |
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected
employer contributions worldwide for pension benefits in 2007
approximate $44.6 million
for the qualified plans, of which $38.1 million was contributed during the nine months ended
September 30, 2007. The portion of the 2007 total expected contributions attributable to the U.S.
qualified pension plans is $28.8 million, of which $27.4 million was contributed during the nine
months ended September 30, 2007. The non-qualified pension plans and other postretirement benefit
plans are unfunded. As a result, the 2007 expected contributions to these plans of $1.8 million
and $4.8 million, respectively, represent actuarial estimates of future assumed payments based on
historic retirement
-16-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
and payment patterns as well as medical trend rates and historical claim
information, as appropriate. The settlement loss in 2006 primarily resulted from a distribution
from a non-qualified pension plan.
12. Restructuring and Impairment Charges
During the three and nine months ended September 30, 2007, the company recorded aggregate
restructuring and impairment charges of $2.1 million and $0.6 million, respectively. The
restructuring and impairment charges during the first nine months of 2007 primarily related to
asset impairment charges of approximately $2.5 million for product lines in the Lubrizol Advanced
Materials segment, offset by a pretax gain and restructuring credit of $2.8 million recorded on the
sale of the manufacturing facility located in Bromborough, U.K. in January 2007 for net cash
proceeds of $5.9 million.
The following table shows the reconciliation of the restructuring liability since January 1, 2007
by major restructuring activity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability |
|
|
Restructuring |
|
|
|
|
|
|
|
|
|
|
|
Liability |
|
|
January 1, |
|
|
and Impairment |
|
|
|
|
|
|
Non-cash |
|
September 30, |
|
|
2007 |
|
|
Charges |
|
Cash Paid |
|
Adjustments |
|
2007 |
Bromborough, U.K. plant closure and sale |
|
|
$ |
1.0 |
|
|
|
|
$ (0.7 |
) |
|
|
$ |
(0.1 |
) |
|
|
$ |
(0.1 |
) |
|
|
$ 0.1 |
|
Lubrizol Advanced Materials plant and
line
closures and workforce reductions |
|
|
|
0.7 |
|
|
|
|
3.2 |
|
|
|
|
(1.0 |
) |
|
|
|
(2.5 |
) |
|
|
0.4 |
|
Corporate / other workforce reductions |
|
|
|
0.2 |
|
|
|
|
0.1 |
|
|
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
Noveon International restructuring
liabilities assumed |
|
|
|
0.9 |
|
|
|
|
|
|
|
|
|
(0.4 |
) |
|
|
|
|
|
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2.8 |
|
|
|
|
$ 2.6 |
|
|
|
$ |
(1.8 |
) |
|
|
$ |
(2.6 |
) |
|
|
$ 1.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included in restructuring and impairment charges for the nine months ended September 30, 2007 was a
$2.0 million gain on the sale of the U.K. plant.
13. Debt
During the three and nine months ended September 30, 2007, the company repaid 25.0 million and
85.0 million, respectively, against its 250.0 million revolving credit agreement. As of
September 30, 2007, there was nothing outstanding under this agreement.
-17-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
14. Shareholders Equity
The following table summarizes the changes in shareholders equity since December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
Number of |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
Shares |
|
|
Common |
|
Retained |
|
|
Comprehensive |
|
|
|
|
|
Outstanding |
|
|
|
Shares |
|
|
|
Earnings |
|
|
|
(Loss) Income |
|
|
|
Total |
|
Balance, December 31, 2006 |
|
|
|
69.0 |
|
|
|
|
$ |
710.1 |
|
|
|
$ |
1,033.8 |
|
|
|
|
$ (60.8 |
) |
|
|
|
$ 1,683.1 |
|
Cumulative effect of a change in
accounting principle due to
the
adoption of FIN No. 48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8.9 |
) |
|
|
|
|
|
|
|
|
(8.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2007 |
|
|
|
69.0 |
|
|
|
|
|
710.1 |
|
|
|
|
1,024.9 |
|
|
|
|
(60.8 |
) |
|
|
|
1,674.2 |
|
|
|
|
|
|
|
|
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
223.7 |
|
|
|
|
|
|
|
|
|
223.7 |
|
Other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65.1 |
|
|
|
|
65.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
288.8 |
|
Dividends |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(62.1 |
) |
|
|
|
|
|
|
|
|
(62.1 |
) |
Deferred stock compensation |
|
|
|
|
|
|
|
|
|
14.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.4 |
|
Common shares treasury: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares purchased |
|
|
|
(1.4 |
) |
|
|
|
|
(2.7 |
) |
|
|
|
(79.4 |
) |
|
|
|
|
|
|
|
|
(82.1 |
) |
Shares issued upon exercise
of stock options and awards |
|
|
|
1.0 |
|
|
|
|
|
34.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2007 |
|
|
|
68.6 |
|
|
|
|
$ |
756.3 |
|
|
|
$ |
1,107.1 |
|
|
|
|
$ 4.3 |
|
|
|
|
$ 1,867.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On April
23, 2007, the companys board of directors authorized a new
share repurchase program that, combined with the companys
existing repurchase program, permits the company to repurchase up to
$300.0 million of its common shares through 2009.
15. Contingencies
The company has numerous purchase commitments for materials, supplies and energy in the ordinary
course of business. The company also has numerous sales commitments for product supply contracts
in the ordinary course of business.
General
There are pending or threatened claims, lawsuits and administrative proceedings against the company
or its subsidiaries, all arising from the ordinary course of business with respect to commercial,
product liability and environmental matters, which seek remedies or damages. The company believes
that any liability that finally may be determined with respect to commercial and product liability
claims should not have a material adverse effect on the companys consolidated financial position,
results of operations or cash flows. From time to time, the company
also may be involved in legal proceedings as a plaintiff involving contract, patent protection,
environmental and other matters. Gain contingencies, if any, are recognized when they are
realized.
-18-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
Environmental
The companys environmental engineers and consultants review and monitor environmental issues at
operating facilities and, where appropriate, the company initiates corrective and/or preventive
environmental projects to ensure environmental compliance and safe and lawful activities at its
current operations. The company also conducts compliance and management systems audits.
The company and its subsidiaries are generators of both hazardous and non-hazardous wastes, the
treatment, storage, transportation and disposal of which are regulated by various laws and
governmental regulations. These laws and regulations generally impose liability for costs to
investigate and remediate contamination without regard to fault and, under certain circumstances,
liability may be joint and several resulting in one party being held responsible for the entire
obligation. Liability also may include damages to natural resources. Although the company
believes past operations were in substantial compliance with the then-applicable regulations,
either the company or the predecessor of Noveon International, the Performance Materials Segment of
Goodrich Corporation (Goodrich), has been designated under a countrys laws and/or regulations as a
potentially responsible party (PRP) in connection with several sites including both third party
sites and/or current operating facilities.
The company participates in the remediation process for onsite and third party waste management
sites at which the company has been identified as a PRP. This process includes investigation,
remedial action selection and implementation, as well as discussions and negotiations with other
parties, which primarily include PRPs, past owners and operators and governmental agencies. The
estimates of environmental liabilities are based on the results of this process. Inherent
uncertainties exist in these estimates primarily due to unknown conditions, changing governmental
regulations and legal standards regarding liability, remediation standards and evolving
technologies for managing investigations and remediation. The company revises its estimates
accordingly as events in this process occur and additional information is obtained.
The companys environmental reserves, measured on an undiscounted basis, totaled $16.6 million at
September 30, 2007 and $14.2 million at December 31, 2006. Of these amounts, $6.5 million and $4.5
million were included in accrued expenses and other current liabilities at September 30, 2007 and
December 31, 2006, respectively. Goodrich provided Noveon International with an indemnity for
various environmental liabilities. The company estimates Goodrichs share of such currently
identified liabilities under the indemnity, which extends through February 2011, to be
approximately $3.7 million of which $0.6 million is included in receivables and $3.1 million is
included in other assets. There are specific environmental contingencies for company-owned sites
for which third parties such as past owners and/or operators are the named PRPs and also for which
the company is indemnified by Goodrich. Goodrich currently is indemnifying Noveon International
for several environmental remediation projects. Goodrichs share of all of these liabilities may
increase to the extent such third parties fail to honor their obligations through February 2011.
The company believes that its environmental accruals are adequate based on currently available
information. The company believes that it is reasonably possible that $12.9 million in additional
costs may be incurred at certain locations beyond the amounts accrued as a result of new
information, newly discovered conditions, changes in remediation standards or technologies or a
change in the law. Additionally, as the indemnification from Goodrich
extends through February 2011, changes in assumptions regarding when costs will be incurred may
result in additional expenses to the company. Additional costs in excess of $12.9 million cannot
currently be estimated.
-19-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
Guarantees
On May 1, 2006, the company sold the FIIS business to SPM Group Holdings, LLC, now known as Emerald
Performance Materials, LLC (Emerald). As a result of the sale, Emerald became responsible for
contracts relating to FIIS, including a Toluene Sale and Purchase Agreement between SK Corporation
(SK) and the company dated December 6, 2005 (the Toluene Agreement). Although Emerald has assumed
the obligations under the Toluene Agreement, the company has guaranteed to SK the timely
performance of Emeralds payment obligations under the Toluene Agreement for purchases thereunder.
The term of the Toluene Agreement extends to January 31, 2008.
If Emerald does not satisfy its obligations under the Toluene Agreement, SK shall notify the
company and use commercially reasonable efforts to collect what is due from Emerald. If SK is
unable to collect from Emerald, then SK may make a demand on the company for payment of the
outstanding obligations. The guarantee is revocable by the company upon 60 days prior written
notice.
Because of the guarantees existing revocation clause, the company estimates that the maximum
liability under the guarantee would be approximately $19.0 million, representing the estimated
liability for two shipments to Emerald. However, the company believes that it is highly unlikely
that an event would occur requiring the company to pay any monies pursuant to the guarantee.
Accordingly, no liability has been reflected in the accompanying consolidated balance sheet at
September 30, 2007.
On
November 5, 2007, the company terminated the guarantee with SK as SK
no longer required a guarantee for Emeralds obligations as of
this date.
Indemnifications
In connection with the sale of the FIIS business, the company has provided indemnifications to
Emerald with respect to the business sold. These indemnifications have been associated with the
price and quantity of raw material purchases and environmental matters. In each of these
circumstances, payment by the company is dependent on Emerald filing a claim. In addition, the
companys obligations under these agreements may be limited in terms of time and/or amount. It is
not possible to predict the maximum potential amount of future payments under certain of these
agreements due to the conditional nature of the companys obligations and the unique facts and
circumstances involved in each particular agreement. The company believes that if it were to incur
a loss in any of these matters, such loss would not have a material effect on the companys
business, financial condition or results of operations. For those indemnification agreements where
a payment by the company is probable and estimable, a liability has been recorded as of September
30, 2007.
16. Restatement of Consolidated Financial Statements
On October 22, 2007, the company concluded to restate its previously issued financial statements
because of reporting errors relating to five postemployment employee benefit plans in three foreign
countries. Accordingly, the company has restated its previously issued financial statements
included in its most recently filed annual report on Form 10-K/A for the fiscal year ended December 31, 2006 and its
previously issued interim financial statements included in its most
recently filed quarterly reports on Form 10-Q/A for
the quarters ended March 31, 2007 and June 30, 2007. As a
result, the company also has restated the accompanying interim
financial statements for the three and nine months ended September
30, 2006.
The impact of the restatement decreased net income for the three and nine months ended September
30, 2006 by $0.7 million or 1.4% and $1.7 million or 2.0%, respectively, from amounts previously
reported. For the three and nine months ended September 30, 2006, the impact of the restatement
decreased income from continuing
operations by $0.7 million or 1.4% and $1.7 million or 1.1%, respectively, from amounts previously
reported. The restatement had no effect on the companys previously reported revenues or net cash
flows.
The errors primarily arose in three different postemployment employee benefit plans at a wholly
owned subsidiary and in postemployment employee benefit plans at two of the companys consolidated
joint ventures. Four of these
-20-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
postemployment employee benefit plans had been accounted for
inappropriately on a cash basis rather than an accrual basis as required by U.S. GAAP, while the
accrual recorded in the financial statements for the fifth plan was not calculated in accordance
with U.S. GAAP.
-21-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
The following tables show the impact of the restatement:
Consolidated Statement of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
(In Millions of Dollars Except Per Share Data) |
|
September 30, 2006 |
|
|
(as previously |
|
|
|
|
|
|
reported) |
|
(adjustments) |
|
(as restated) |
Net sales |
|
|
$ 1,029.9 |
|
|
|
$ |
|
|
|
$ 1,029.9 |
|
Royalties and other revenues |
|
|
1.1 |
|
|
|
|
|
|
|
1.1 |
|
|
|
|
|
|
Total revenues |
|
|
1,031.0 |
|
|
|
|
|
|
|
1,031.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
781.8 |
|
|
|
1.0 |
|
|
|
782.8 |
|
Selling and administrative expenses |
|
|
101.7 |
|
|
|
|
|
|
|
101.7 |
|
Research, testing and development expenses |
|
|
50.5 |
|
|
|
|
|
|
|
50.5 |
|
Amortization of intangible assets |
|
|
5.9 |
|
|
|
|
|
|
|
5.9 |
|
Restructuring and impairment charges |
|
|
2.7 |
|
|
|
|
|
|
|
2.7 |
|
|
|
|
|
|
Total costs and expenses |
|
|
942.6 |
|
|
|
1.0 |
|
|
|
943.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense net |
|
|
1.6 |
|
|
|
|
|
|
|
1.6 |
|
Interest income |
|
|
7.6 |
|
|
|
|
|
|
|
7.6 |
|
Interest expense |
|
|
(25.0 |
) |
|
|
|
|
|
|
(25.0 |
) |
|
|
|
|
|
Income from continuing operations before income taxes |
|
|
72.6 |
|
|
|
(1.0 |
) |
|
|
71.6 |
|
Provision for income taxes |
|
|
21.8 |
|
|
|
(0.3 |
) |
|
|
21.5 |
|
|
|
|
|
|
Income from continuing operations |
|
|
50.8 |
|
|
|
(0.7 |
) |
|
|
50.1 |
|
Discontinued operations net of tax |
|
|
(0.5 |
) |
|
|
|
|
|
|
(0.5 |
) |
|
|
|
|
|
Net income |
|
|
$ 50.3 |
|
|
|
$ (0.7 |
) |
|
|
$ 49.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
|
$ 0.74 |
|
|
|
$ (0.01 |
) |
|
|
$ 0.73 |
|
Discontinued operations |
|
|
(0.01 |
) |
|
|
|
|
|
|
(0.01 |
) |
|
|
|
|
|
Net income per share, basic |
|
|
$ 0.73 |
|
|
|
$ (0.01 |
) |
|
|
$ 0.72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
|
$ 0.73 |
|
|
|
$ (0.01 |
) |
|
|
$ 0.72 |
|
Discontinued operations |
|
|
(0.01 |
) |
|
|
|
|
|
|
(0.01 |
) |
|
|
|
|
|
Net income per share, diluted |
|
|
$ 0.72 |
|
|
|
$ (0.01 |
) |
|
|
$ 0.71 |
|
|
|
|
|
|
-22-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
Consolidated Statement of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
(In Millions of Dollars Except Per Share Data) |
|
September 30, 2006 |
|
|
|
(as previously |
|
|
|
|
|
|
reported) |
|
(adjustments) |
|
(as restated) |
Net sales |
|
|
$ 3,053.2 |
|
|
|
$ |
|
|
|
$ 3,053.2 |
|
Royalties and other revenues |
|
|
3.0 |
|
|
|
|
|
|
|
3.0 |
|
|
|
|
|
|
Total revenues |
|
|
3,056.2 |
|
|
|
|
|
|
|
3,056.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
2,294.8 |
|
|
|
2.6 |
|
|
|
2,297.4 |
|
Selling and administrative expenses |
|
|
280.6 |
|
|
|
|
|
|
|
280.6 |
|
Research, testing and development expenses |
|
|
152.8 |
|
|
|
|
|
|
|
152.8 |
|
Amortization of intangible assets |
|
|
17.7 |
|
|
|
|
|
|
|
17.7 |
|
Restructuring and impairment charges |
|
|
6.3 |
|
|
|
|
|
|
|
6.3 |
|
|
|
|
|
|
Total costs and expenses |
|
|
2,752.2 |
|
|
|
2.6 |
|
|
|
2,754.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense net |
|
|
(0.1 |
) |
|
|
|
|
|
|
(0.1 |
) |
Interest income |
|
|
13.5 |
|
|
|
|
|
|
|
13.5 |
|
Interest expense |
|
|
(75.0 |
) |
|
|
|
|
|
|
(75.0 |
) |
|
|
|
|
|
Income from continuing operations before income taxes |
|
|
242.4 |
|
|
|
(2.6 |
) |
|
|
239.8 |
|
Provision for income taxes |
|
|
82.3 |
|
|
|
(0.9 |
) |
|
|
81.4 |
|
|
|
|
|
|
Income from continuing operations |
|
|
160.1 |
|
|
|
(1.7 |
) |
|
|
158.4 |
|
Discontinued operations net of tax |
|
|
(73.6 |
) |
|
|
|
|
|
|
(73.6 |
) |
|
|
|
|
|
Net income |
|
|
$ 86.5 |
|
|
|
$ (1.7 |
) |
|
|
$ 84.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
|
$ 2.33 |
|
|
|
$ (0.02 |
) |
|
|
$ 2.31 |
|
Discontinued operations |
|
|
(1.07 |
) |
|
|
|
|
|
|
(1.07 |
) |
|
|
|
|
|
Net income per share, basic |
|
|
$ 1.26 |
|
|
|
$ (0.02 |
) |
|
|
$ 1.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
|
$ 2.31 |
|
|
|
$ (0.02 |
) |
|
|
$ 2.29 |
|
Discontinued operations |
|
|
(1.06 |
) |
|
|
|
|
|
|
(1.06 |
) |
|
|
|
|
|
Net income per share, diluted |
|
|
$ 1.25 |
|
|
|
$ (0.02 |
) |
|
|
$ 1.23 |
|
|
|
|
|
|
-23-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2007
(Unaudited)
Consolidated Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
September 30, 2006 |
|
|
(as previously |
|
|
|
|
(In Millions of Dollars) |
|
reported) |
|
(adjustments) |
|
(as restated) |
|
CASH PROVIDED BY (USED FOR): |
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
$ 86.5 |
|
|
|
$ (1.7 |
) |
|
|
$ 84.8 |
|
Adjustments to reconcile net income to cash
provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
120.8 |
|
|
|
|
|
|
|
120.8 |
|
Deferred income taxes |
|
|
33.1 |
|
|
|
(0.9 |
) |
|
|
32.2 |
|
Deferred compensation |
|
|
12.9 |
|
|
|
|
|
|
|
12.9 |
|
Restructuring and impairment charges |
|
|
61.6 |
|
|
|
|
|
|
|
61.6 |
|
Loss from divestitures and sales of property and equipment |
|
|
5.2 |
|
|
|
|
|
|
|
5.2 |
|
Change in current assets and liabilities, net of acquisitions and divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
Receivables |
|
|
(45.0 |
) |
|
|
|
|
|
|
(45.0 |
) |
Inventories |
|
|
(28.8 |
) |
|
|
|
|
|
|
(28.8 |
) |
Accounts payable, accrued expenses and other current liabilities |
|
|
(23.4 |
) |
|
|
(0.7 |
) |
|
|
(24.1 |
) |
Other current assets |
|
|
9.5 |
|
|
|
|
|
|
|
9.5 |
|
|
|
|
|
|
|
|
|
(87.7 |
) |
|
|
(0.7 |
) |
|
|
(88.4 |
) |
Change in noncurrent liabilities |
|
|
4.3 |
|
|
|
1.2 |
|
|
|
5.5 |
|
Other items net |
|
|
8.4 |
|
|
|
2.1 |
|
|
|
10.5 |
|
|
|
|
|
|
Total operating activities |
|
|
245.1 |
|
|
|
|
|
|
|
245.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(91.2 |
) |
|
|
|
|
|
|
(91.2 |
) |
Net proceeds from divestitures and sales of property and equipment |
|
|
281.4 |
|
|
|
|
|
|
|
281.4 |
|
Other items net |
|
|
(0.8 |
) |
|
|
|
|
|
|
(0.8 |
) |
|
|
|
|
|
Total investing activities |
|
|
189.4 |
|
|
|
|
|
|
|
189.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
|
Changes in short-term debt net |
|
|
4.5 |
|
|
|
|
|
|
|
4.5 |
|
Repayments of long-term debt |
|
|
(114.3 |
) |
|
|
|
|
|
|
(114.3 |
) |
Dividends paid |
|
|
(53.3 |
) |
|
|
|
|
|
|
(53.3 |
) |
Proceeds from the exercise of stock options |
|
|
17.9 |
|
|
|
|
|
|
|
17.9 |
|
|
|
|
|
|
Total financing activities |
|
|
(145.2 |
) |
|
|
|
|
|
|
(145.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
8.0 |
|
|
|
|
|
|
|
8.0 |
|
|
|
|
|
|
Net increase in cash and short-term investments |
|
|
297.3 |
|
|
|
|
|
|
|
297.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments at the beginning of period |
|
|
262.4 |
|
|
|
|
|
|
|
262.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments at the end of period |
|
|
$ 559.7 |
|
|
|
$ |
|
|
|
$ 559.7 |
|
|
|
|
|
|
-24-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
(In Millions of Dollars except Share and Per Share Data)
This Managements Discussion and Analysis of Financial Condition and Results of Operations should
be read in conjunction with the unaudited consolidated financial statements and the notes thereto
appearing elsewhere in this quarterly report on Form 10-Q. Historical results and percentage
relationships set forth in the consolidated financial statements, including trends that might
appear, should not be taken as indicative of future operations. The following discussion contains
forward-looking statements that involve risks and uncertainties. Our actual results may differ
materially from those discussed in such forward-looking statements as a result of various factors,
including those described under the section Cautionary Statements for Safe Harbor Purposes
included elsewhere in this quarterly report on Form 10-Q.
On October 22, 2007, we concluded to restate our previously issued financial statements because of
reporting errors relating to five postemployment employee benefit plans in three foreign countries.
Accordingly, the effects of the restatement have been reflected in this
Managements Discussion and Analysis of Financial
Condition and Results of Operations and we have not modified or
updated disclosures except as required to reflect the effects of the
restatement. See the
Explanatory Note included in the front section of this quarterly
report on Form 10-Q and Note 16 - Restatement
of Consolidated Financial Statements contained in the Notes to Financial Statements for more
information regarding the restatement and changes to previously issued financial statements.
The impact of the restatement decreased net income for the three and nine months ended September
30, 2006 by $0.7 million or 1.4% and $1.7 million or 2.0%, respectively, from amounts previously
reported. For the three and nine months ended September 30, 2006, the impact of the restatement
decreased income from continuing operations by $0.7 million or 1.4% and $1.7 million or 1.1%,
respectively, from amounts previously reported. The effect of the restatement is not significant
to our reported expenses and the changes resulting from these restatements had no effect on our
previously reported revenues or net cash flows.
OVERVIEW
We are an innovative specialty chemical company that produces and supplies technologies that
improve the quality and performance of our customers products in the global transportation,
industrial and consumer markets. Our business is founded on technological leadership. Innovation
provides opportunities for us in growth markets as well as advantages over our competitors. From a
base of approximately 1,600 patents, we use our product development and formulation expertise to
sustain our leading market positions and fuel our future growth. We create additives, ingredients,
resins and compounds that enhance the performance, quality and value of our customers products,
while minimizing their environmental impact. Our products are used in a broad range of
applications, and are sold into stable markets such as those for engine oils, specialty driveline
lubricants and metalworking fluids, as well as higher-growth markets such as personal care and
over-the-counter pharmaceutical products and performance coatings and inks. Our engineered
polymers products also are used in a variety of industries, including the construction, sporting
goods, medical products and automotive industries. We are an industry leader in many of the
markets in which our product lines compete.
We are geographically diverse, with an extensive global manufacturing, supply chain, technical and
commercial infrastructure. We operate facilities in 28 countries, including production facilities
in 19 countries and laboratories
in 13 countries, in key regions around the world through the efforts of approximately 6,850
employees. We sell our products in more than 100 countries and believe that our customers value
our ability to provide customized, high-quality, cost-effective performance formulations and
solutions worldwide. We also believe that our customers value our global supply chain
capabilities.
-25-
On November 1, 2007, the company completed the acquisition of the refrigeration lubricants business
of Croda International Plc (Croda) for approximately $124.1 million.
The acquisition primarily includes
lubricant technology, trade names, customer lists, manufacturing
know-how and inventory. No manufacturing facilities are included in the transaction. Annualized
revenues for this business are approximately $84.0 million.
On February 7, 2007, we completed the acquisition of the entire metalworking additives product line
of Lockhart Chemical Company (Lockhart), a private company with headquarters in Gibsonia,
Pennsylvania. Annualized revenues of these products are approximately $20.0 million.
In May 2006, we sold the food ingredients and industrial specialties business (FIIS) and the active
pharmaceutical ingredients and intermediate compounds business (A&I), both of which were included
in the Lubrizol Advanced Materials segment. We have reflected the results of these divested
businesses in the discontinued operations - net of tax line item in the consolidated statements of
income for the three and nine months ended September 30, 2006.
In February 2006, we sold certain assets and liabilities of our Telene® resins business
(Telene), which was included in the Lubrizol Advanced Materials segment. We have reflected the
results of Telene in the discontinued operations - net of tax line item in the consolidated
statement of income for the nine months ended September 30, 2006.
RESULTS OF OPERATIONS
Income from continuing operations increased $21.3 million to $71.4 million for the three months
ended September 30, 2007 compared to the three months ended September 30, 2006 and increased $65.3
million to $223.7 million for the nine months ended September 30, 2007 compared to the nine months
ended September 30, 2006. The increase in earnings from continuing operations for the three-month
period primarily was due to improvements in the combination of price and product mix in the
Lubrizol Additives segment, an increase in volume, the favorable resolution of tax matters from
prior years, favorable currency gains included in other income and reduced net interest expense.
The increase in earnings from continuing operations for the nine-month comparative period primarily
was a result of improvements in the combination of price and product mix in the Lubrizol Additives
segment as we continued to recover lost margin attributable to past raw material cost increases in
this segment. The nine-month period also was favorably impacted by higher volume, the resolution
of tax matters from prior years, lower net interest costs, higher other income including a gain on
the sale of land and currency gains and a net decrease in restructuring-related charges. Higher
raw material costs, increased manufacturing costs and higher selling, technology, administrative
and research (STAR) expenses partially offset improvements in income from continuing operations for
both the three-month and nine-month comparative periods.
Net income of $49.6 million for the three months ended September 30, 2006 included a $0.5 million
loss from discontinued operations - net of tax. Net income of $84.8 million for the nine months
ended September 30, 2006 included a $73.6 million loss from
discontinued operations - net of tax,
which primarily was comprised of a $60.6 million after-tax impairment charge recorded to reflect
the FIIS business at its fair value and losses on the sales of the FIIS and A&I businesses.
Revenues
The changes in consolidated revenues are summarized as follows:
-26-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
2007 |
|
2006 |
|
$ Change |
|
% Change |
Net sales |
|
|
$ 1,120.4 |
|
|
|
$ 1,029.9 |
|
|
|
$ 90.5 |
|
|
|
9 |
% |
|
Royalties and other revenues |
|
|
1.0 |
|
|
|
1.1 |
|
|
|
(0.1 |
) |
|
|
(9 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
$ 1,121.4 |
|
|
|
$ 1,031.0 |
|
|
|
$ 90.4 |
|
|
|
9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
2007 |
|
2006 |
|
$ Change |
|
% Change |
Net sales |
|
|
$ 3,349.7 |
|
|
|
$ 3,053.2 |
|
|
|
$ 296.5 |
|
|
|
10 |
% |
|
Royalties and other revenues |
|
|
3.0 |
|
|
|
3.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
$ 3,352.7 |
|
|
|
$ 3,056.2 |
|
|
|
$ 296.5 |
|
|
|
10 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The increase in revenues for the three months ended September 30, 2007 compared to the same period
in 2006 was due to a 4% increase in volume, a 3% improvement in the combination of price and
product mix and a 2% favorable currency impact. The increase in revenues for the nine months ended
September 30, 2007 compared to the same period in 2006 was due to a 6% improvement in the
combination of price and product mix, a 2% increase in volume and a 2% favorable currency impact.
The following table shows the geographic break-down of our volume for the three and nine months
ended September 30, 2007:
|
|
|
|
|
|
|
|
|
|
|
2007 Volume |
|
|
3rd Quarter |
|
Year-to-Date |
North America |
|
|
46 |
% |
|
|
47 |
% |
Europe |
|
|
26 |
% |
|
|
26 |
% |
Asia-Pacific / Middle East |
|
|
21 |
% |
|
|
21 |
% |
Latin America |
|
|
7 |
% |
|
|
6 |
% |
|
|
|
|
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
|
|
|
|
The following table shows the percentage change in our volume by geographic zone for the three and
nine months ended September 30, 2007 compared to the corresponding periods in 2006:
-27-
|
|
|
|
|
|
|
|
|
|
|
2007 vs. 2006 |
|
|
% Change |
|
|
3rd Quarter |
|
Year-to-Date |
North America |
|
|
(1 |
%) |
|
|
(1 |
%) |
Europe |
|
|
3 |
% |
|
|
5 |
% |
Asia-Pacific / Middle East |
|
|
9 |
% |
|
|
2 |
% |
Latin America |
|
|
25 |
% |
|
|
24 |
% |
Total |
|
|
4 |
% |
|
|
2 |
% |
Segment volume variances by geographic zone as well as the factors explaining the changes in
segment revenues for the three and nine months ended September 30, 2007 compared with the same
periods in 2006 are contained within the Segment Analysis section below.
Costs and Expenses
The changes in consolidated costs and expenses are summarized as follows:
-28-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
2007 |
|
2006 |
|
$ Change |
|
% Change |
Cost of sales |
|
|
$ 846.0 |
|
|
|
$ 782.8 |
|
|
|
$ 63.2 |
|
|
|
8 |
% |
|
Selling and administrative expenses |
|
|
103.7 |
|
|
|
101.7 |
|
|
|
2.0 |
|
|
|
2 |
% |
|
Research, testing and development expenses |
|
|
56.0 |
|
|
|
50.5 |
|
|
|
5.5 |
|
|
|
11 |
% |
|
Amortization of intangible assets |
|
|
5.8 |
|
|
|
5.9 |
|
|
|
(0.1 |
) |
|
|
(2 |
%) |
|
Restructuring and impairment charges |
|
|
2.1 |
|
|
|
2.7 |
|
|
|
(0.6 |
) |
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
$ 1,013.6 |
|
|
|
$ 943.6 |
|
|
|
$ 70.0 |
|
|
|
7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
2007 |
|
2006 |
|
$ Change |
|
% Change |
Cost of sales |
|
|
$ 2,503.0 |
|
|
|
$ 2,297.4 |
|
|
|
$ 205.6 |
|
|
|
9 |
% |
|
Selling and administrative expenses |
|
|
309.4 |
|
|
|
280.6 |
|
|
|
28.8 |
|
|
|
10 |
% |
|
Research, testing and development expenses |
|
|
161.4 |
|
|
|
152.8 |
|
|
|
8.6 |
|
|
|
6 |
% |
|
Amortization of intangible assets |
|
|
17.7 |
|
|
|
17.7 |
|
|
|
|
|
|
|
|
|
|
Restructuring and impairment charges |
|
|
0.6 |
|
|
|
6.3 |
|
|
|
(5.7 |
) |
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
$ 2,992.1 |
|
|
|
$ 2,754.8 |
|
|
|
$ 237.3 |
|
|
|
9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Calculation not meaningful |
The increases in cost of sales for the three and nine months ended September 30, 2007 compared to
the same periods in 2006 primarily were due to higher average raw material cost and higher
manufacturing expenses. Average raw material cost increased 3% and 6% in the three and nine months
ended September 30, 2007, respectively, compared to the same periods in 2006. Total manufacturing
expenses increased 10% and 11% in the three and nine months ended September 30, 2007, respectively,
compared to the same periods in 2006. The increases in manufacturing expenses for both comparative
periods primarily were due to an unfavorable currency impact, increased environmental-related
charges and higher maintenance materials and contract labor costs in the Lubrizol Additives segment
mostly attributable to the U.S. Gulf Coast. The nine-month comparative period also included higher
salaries and benefits and unfavorable manufacturing cost absorption as we lowered first quarter
production to reduce inventory levels from the prior year end. The nine-month increase in
manufacturing expenses partially was offset by a decrease in utility costs. On a per-unit-sold
basis, manufacturing costs increased 6% and 8% in the three and nine months ended September 30,
2007 compared to the same periods in 2006.
Gross profit (net sales less cost of sales) increased $27.3 million, or 11%, and $90.9 million, or
12%, for the three and nine months ended September 30, 2007, respectively, compared to the same
periods in 2006. The increases primarily were due to improvement in the combination of price and
product mix in the Lubrizol Additives segment, increased volume and a favorable currency impact
offset by higher average unit raw material cost and higher manufacturing cost. Our gross profit
percentage (gross profit divided by net sales) increased to 24.5% and 25.3% for the three and nine
months ended September 30, 2007, respectively, compared to 24.0% and 24.8% in the same periods last
year. The increases in gross profit percentage for the three-month and nine-month comparative
periods were attributable to increases in the Lubrizol Additives segment gross profit percentage
largely due to the favorable combination of price and product mix and increased volume, partially
offset by gross profit percentage decreases in the Lubrizol Advanced Materials segment primarily as
a result of higher raw material costs.
Selling and administrative expenses increased $2.0 million, or 2%, and $28.8 million, or 10%, for
the three and nine months ended September 30, 2007, respectively, compared to the same periods in
2006. The increase for the nine-
-29-
month period primarily was due to an increase in salaries and
benefits as a result of annual merit increases, higher incentive compensation expense, the funding
of growth resources and implementation of a common information
systems platform in the Lubrizol Advanced Materials segment and an unfavorable currency impact.
The first quarter of 2006 included a $2.8 million pension settlement charge related to a
non-qualified pension plan distribution.
Research, testing and development expenses increased $5.5 million, or 11%, and $8.6 million, or 6%,
for the three and nine months ended September 30, 2007, respectively, compared to the same periods
in the prior year. The increases for both periods primarily were due to an unfavorable currency
impact and increased salaries and benefits.
In the three and nine months ended September 30, 2007, we recorded aggregate restructuring and
impairment charges of $2.1 million and $0.6 million, respectively. The restructuring charges for
the nine-month period primarily related to impairment charges of approximately $2.5 million for
product lines in the Lubrizol Advanced Materials segment, offset by a pretax gain and restructuring
credit of $2.8 million recorded on the sale of the manufacturing facility located in Bromborough,
U.K. in January 2007 for net cash proceeds of $5.9 million. Restructuring and impairment charges
of $2.7 million and $6.3 million were recorded during the three and nine months ended September 30,
2006, respectively, which primarily were associated with the U.K. plant closure mentioned above.
The components of restructuring and impairment charges are detailed as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2007 |
|
|
Asset |
|
Other Plant |
|
|
|
|
|
Impairments |
|
Exit Costs |
|
Severance |
|
Total |
Lubrizol Advanced Materials production line
impairment and workforce reductions |
|
|
$ |
2.0 |
|
|
|
$ |
|
|
|
|
$ |
0.1 |
|
|
|
$ |
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2007 |
|
|
Asset |
|
|
|
|
|
|
|
|
Impairments |
|
Other Plant |
|
|
|
|
|
|
(Gains) |
|
Exit Costs |
|
Severance |
|
Total |
Lubrizol Advanced Materials plant closures,
production line impairments and workforce reductions |
|
|
$ |
2.5 |
|
|
|
$ |
0.2 |
|
|
|
$ |
0.6 |
|
|
|
$ |
3.3 |
|
Bromborough, U.K. plant closure and sale |
|
|
|
(2.8 |
) |
|
|
|
0.1 |
|
|
|
|
|
|
|
|
|
(2.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total restructuring and impairment charges |
|
|
$ |
(0.3 |
) |
|
|
$ |
0.3 |
|
|
|
$ |
0.6 |
|
|
|
$ |
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2006 |
|
|
Asset |
|
Other Plant |
|
|
|
|
|
|
Impairments |
|
Exit Costs |
|
Severance |
|
Total |
Lubrizol Advanced Materials plant closures
and workforce reductions |
|
|
$ |
0.6 |
|
|
|
$ |
0.3 |
|
|
|
$ |
0.3 |
|
|
|
$ |
1.2 |
|
Bromborough, U.K. plant closure |
|
|
|
|
|
|
|
|
1.2 |
|
|
|
|
0.5 |
|
|
|
|
1.7 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.2 |
) |
|
|
|
(0.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total restructuring and impairment charges |
|
|
$ |
0.6 |
|
|
|
$ |
1.5 |
|
|
|
$ |
0.6 |
|
|
|
$ |
2.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-30-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2006 |
|
|
Asset |
|
Other Plant |
|
|
|
|
|
|
Impairments |
|
Exit Costs |
|
Severance |
|
Total |
Lubrizol Advanced Materials plant closures
and workforce reductions |
|
|
$ 0.6 |
|
|
|
$ 0.3 |
|
|
|
$ 0.8 |
|
|
|
$ 1.7 |
|
Bromborough, U.K. plant closure |
|
|
|
|
|
|
3.3 |
|
|
|
1.6 |
|
|
|
4.9 |
|
Other |
|
|
|
|
|
|
|
|
|
|
(0.3 |
) |
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total restructuring and impairment charges |
|
|
$ 0.6 |
|
|
|
$ 3.6 |
|
|
|
$ 2.1 |
|
|
|
$ 6.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The charges for these cost reduction initiatives and impairments are reported as a separate line
item in the consolidated statements of income, entitled Restructuring and impairment charges and
are included in the Total cost and expenses subtotal on the consolidated statements of income.
-31-
Other
Items and Net Income
The changes in other items and net income are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
2007 |
|
2006 |
|
$ Change |
|
% Change |
Other income (expense) net |
|
|
$ 5.5 |
|
|
|
$ 1.6 |
|
|
|
$ 3.9 |
|
|
|
* |
|
|
Interest expense net |
|
|
(14.8 |
) |
|
|
(17.4 |
) |
|
|
2.6 |
|
|
|
(15 |
%) |
|
Income from continuing operations
before income taxes |
|
|
98.5 |
|
|
|
71.6 |
|
|
|
26.9 |
|
|
|
38 |
% |
|
Provision for income taxes |
|
|
27.1 |
|
|
|
21.5 |
|
|
|
5.6 |
|
|
|
26 |
% |
|
Income from continuing operations |
|
|
71.4 |
|
|
|
50.1 |
|
|
|
21.3 |
|
|
|
43 |
% |
|
Discontinued operations |
|
|
|
|
|
|
(0.5 |
) |
|
|
0.5 |
|
|
|
* |
|
|
Net income |
|
|
71.4 |
|
|
|
49.6 |
|
|
|
21.8 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
2007 |
|
2006 |
|
$ Change |
|
% Change |
Other income (expense) net |
|
|
$ 9.7 |
|
|
|
$ (0.1 |
) |
|
|
$ 9.8 |
|
|
|
* |
|
|
Interest expense net |
|
|
(49.4 |
) |
|
|
(61.5 |
) |
|
|
12.1 |
|
|
|
(20 |
%) |
|
Income from continuing operations
before income taxes |
|
|
320.9 |
|
|
|
239.8 |
|
|
|
81.1 |
|
|
|
34 |
% |
|
Provision for income taxes |
|
|
97.2 |
|
|
|
81.4 |
|
|
|
15.8 |
|
|
|
19 |
% |
|
Income from continuing operations |
|
|
223.7 |
|
|
|
158.4 |
|
|
|
65.3 |
|
|
|
41 |
% |
|
Discontinued operations |
|
|
|
|
|
|
(73.6 |
) |
|
|
73.6 |
|
|
|
* |
|
|
Net income |
|
|
223.7 |
|
|
|
84.8 |
|
|
|
138.9 |
|
|
|
* |
|
|
|
|
|
* |
|
Calculation not meaningful |
The increases in other income for the three and nine months ended September 30, 2007 compared to
the same periods in 2006 primarily were due to favorable currency gains. In addition, the
nine-month period was impacted favorably by a $5.0 million gain on the sale of land recorded in the
first quarter of 2007.
The
decrease in interest expense - net for the nine months ended September 30, 2007 compared to the
same period in 2006 primarily was attributable to an increase in interest income as a result of our
increased cash and short-term investments from the divestiture proceeds received in May 2006 and
reduced interest expense associated with our reduced debt balances.
Our effective tax rates were 27.5% and 30.3% for the three and nine months ended September 30,
2007, respectively, compared to our effective tax rates of 30.0% and 33.9% for the same respective
periods in 2006. The decreases in both periods in 2007 compared to 2006 primarily were due to the
favorable resolution of tax matters from prior years and an improvement in our geographic earnings
mix as a result of our strong international growth.
Primarily as a result of the above factors, net income per diluted share was $1.02 and $3.19 for
the three and nine months ended September 30, 2007, respectively, compared to net income per
diluted share of $0.71 and $1.23 for the same respective periods in 2006. Net income per diluted
share for the three and nine months ended September 30,
2006 included a loss from discontinued operations per diluted share of $0.01 and $1.06,
respectively. The loss from
-32-
discontinued operations per diluted share for the nine months ended
September 30, 2006 included a $0.01 per diluted share of operating income, an $0.87 per diluted
share non-cash impairment charge and a $0.20 per diluted share loss on the sale of the FIIS, A&I
and Telene businesses.
SEGMENT ANALYSIS
We primarily evaluate performance and allocate resources based on segment operating income, defined
as revenues less expenses identifiable to the product lines included within each segment, as well
as projected future returns. Segment operating income will reconcile to consolidated income from
continuing operations before income taxes by deducting corporate expenses and income that are not
attributable to the operating segments, restructuring and impairment charges and net interest
expense.
The proportion of consolidated revenues and segment operating income attributed to each segment was
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives |
|
|
66 |
% |
|
|
64 |
% |
|
|
65 |
% |
|
|
64 |
% |
Lubrizol Advanced Materials |
|
|
34 |
% |
|
|
36 |
% |
|
|
35 |
% |
|
|
36 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Operating Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives |
|
|
76 |
% |
|
|
62 |
% |
|
|
72 |
% |
|
|
63 |
% |
Lubrizol Advanced Materials |
|
|
24 |
% |
|
|
38 |
% |
|
|
28 |
% |
|
|
37 |
% |
-33-
The operating results by segment were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
2006 |
|
|
|
$ Change |
|
|
% Change |
|
|
2007 |
|
|
|
2006 |
|
|
$ Change |
|
|
% Change |
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives |
|
|
$ 738.8 |
|
|
|
$ 661.3 |
|
|
|
$ 77.5 |
|
|
|
12 |
% |
|
|
$ 2,193.8 |
|
|
|
$ 1,967.3 |
|
|
|
$ 226.5 |
|
|
|
12 |
% |
Lubrizol Advanced Materials |
|
|
382.6 |
|
|
|
369.7 |
|
|
|
12.9 |
|
|
|
3 |
% |
|
|
1,158.9 |
|
|
|
1,088.9 |
|
|
|
70.0 |
|
|
|
6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
$ 1,121.4 |
|
|
|
$ 1,031.0 |
|
|
|
$ 90.4 |
|
|
|
9 |
% |
|
|
$ 3,352.7 |
|
|
|
$ 3,056.2 |
|
|
|
$ 296.5 |
|
|
|
10 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives |
|
|
$ 175.7 |
|
|
|
$ 139.7 |
|
|
|
$ 36.0 |
|
|
|
26 |
% |
|
|
$ 528.7 |
|
|
|
$ 438.9 |
|
|
|
$ 89.8 |
|
|
|
20 |
% |
Lubrizol Advanced Materials |
|
|
98.7 |
|
|
|
107.4 |
|
|
|
(8.7 |
) |
|
|
(8 |
%) |
|
|
318.0 |
|
|
|
316.9 |
|
|
|
1.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
$ 274.4 |
|
|
|
$ 247.1 |
|
|
|
$ 27.3 |
|
|
|
11 |
% |
|
|
$ 846.7 |
|
|
|
$ 755.8 |
|
|
|
$ 90.9 |
|
|
|
12 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Operating Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives |
|
|
$ 97.0 |
|
|
|
$ 70.6 |
|
|
|
$ 26.4 |
|
|
|
37 |
% |
|
|
$ 304.3 |
|
|
|
$ 233.4 |
|
|
|
$ 70.9 |
|
|
|
30 |
% |
Lubrizol Advanced Materials |
|
|
30.9 |
|
|
|
42.5 |
|
|
|
(11.6 |
) |
|
|
(27 |
%) |
|
|
119.8 |
|
|
|
135.4 |
|
|
|
(15.6 |
) |
|
|
(12 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
$ 127.9 |
|
|
|
$ 113.1 |
|
|
|
$ 14.8 |
|
|
|
13 |
% |
|
|
$ 424.1 |
|
|
|
$ 368.8 |
|
|
|
$ 55.3 |
|
|
|
15 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubrizol Additives Segment
Revenues increased 12% for both the three and nine months ended September 30, 2007 compared to the
same periods in 2006. The three-month increase was due to a 5% increase in volume, a 5%
improvement in the combination of price and product mix and a 2% favorable currency impact. The
nine-month increase resulted from a 7% improvement in the combination of price and product mix, a
3% favorable currency impact and a 2% increase in volume.
The following table shows the geographic break-down of our volume for the three and nine months
ended September 30, 2007:
|
|
|
|
|
|
|
|
|
|
|
2007 Volume |
|
|
3rd Quarter |
|
Year-to-Date |
North America |
|
|
36% |
|
|
|
37% |
|
Europe |
|
|
30% |
|
|
|
31% |
|
Asia-Pacific / Middle East |
|
|
25% |
|
|
|
25% |
|
Latin America |
|
|
9% |
|
|
|
7% |
|
|
|
|
|
|
|
|
|
|
Total |
|
|
100% |
|
|
|
100% |
|
|
|
|
|
|
|
|
|
|
The following table shows the percentage change in our volume by geographic zone for the three and
nine months ended September 30, 2007 compared to the corresponding periods in 2006:
-34-
|
|
|
|
|
|
|
|
|
|
|
2007 vs. 2006 |
|
|
% Change |
|
|
3rd Quarter |
|
Year-to-Date |
North America |
|
|
(2 |
%) |
|
|
(2 |
%) |
Europe |
|
|
4 |
% |
|
|
4 |
% |
Asia-Pacific / Middle East |
|
|
7 |
% |
|
|
(1 |
%) |
Latin America |
|
|
34 |
% |
|
|
25 |
% |
Total |
|
|
5 |
% |
|
|
2 |
% |
Volume for the three-month and nine-month periods ended September 30, 2007 were at record levels
primarily due to business gains in Europe and Latin America, which partially were offset by volume
declines in North America. The volume decrease in North America primarily was due to our decision
to exit low margin fuel additive business and the impact of lower commercial vehicle builds on
customer demand for lubricant additives. The volume decrease in the year-to-date period in
Asia-Pacific / Middle East primarily was attributable to a strong first half of 2006 influenced by
changes in customer order patterns.
Segment gross profit increased 26% and 20% for the three and nine months ended September 30, 2007,
respectively, compared to the same periods in 2006 as we continued to recover margin lost in prior
periods. The Lubrizol Additives segment implemented a series of price increases in 2005 and 2006
in response to continued raw material and manufacturing cost increases. The effective dates of the
selling price increases varied by geographic sales zone. Gross profit improved primarily due to
the combination of price and product mix, partially offset by a 3% and 6% increase in average raw
material cost for the three and nine months ended September 30, 2007, respectively, as compared to
the same periods in 2006. Manufacturing costs on a per-unit-sold basis increased 5% and 10% for
the three-month and nine-month comparative periods, respectively, primarily due to the impact of
unfavorable currency, increased costs for environmental matters and higher manufacturing costs for
maintenance materials and contract labor costs mostly attributable to the U.S. Gulf Coast. In
addition, for the nine months ended September 30, 2007 we experienced unfavorable manufacturing
cost absorption as we lowered first quarter production to reduce inventory levels from the prior
year end. These cost increases partially were offset by decreases in utility costs for both the
three and nine months ended September 30, 2007 compared to the same periods in 2006.
The gross profit percentage increased to 23.8% and 24.1% for the three and nine months ended
September 30, 2007, respectively, as compared to 21.2% and 22.3% in the corresponding prior-year
periods. The increases in gross profit percentage primarily related to the improvement in the
combination of price and product mix and the favorable impact of currency.
STAR expenses increased 12% and 10% in the three and nine months ended September 30, 2007 compared
to the respective prior-year periods. The increases primarily were due to higher selling and
administrative expenses resulting from increased incentive compensation expense and unfavorable
currency. In addition, technical expenses increased in both periods, with higher outside testing
costs occurring in the three months ended September 30, 2007.
Other income for the year-to-date period includes a $5.0 million gain on the sale of land recorded
in the first quarter of 2007.
Segment operating income increased 37% and 30% for the three and nine months ended September 30,
2007, respectively, compared to the same periods in 2006 due to the factors discussed above.
-35-
lubrizol advanced materials Segment
Revenues increased 3% and 6% for the three and nine months ended September 30, 2007, respectively,
compared to the same periods in 2006. The increase for the three-month period was due to a 2%
increase in volume and a 2% favorable currency impact offset by a 1% decrease in the combination of
price and product mix. The increase for the nine-month period was due to a 3% increase in volume,
a 2% favorable currency impact, and a 1% increase in the combination of price and product mix.
The following table shows the geographic break-down of our volume for the three and nine months
ended September 30, 2007:
|
|
|
|
|
|
|
|
|
|
|
2007 Volume |
|
|
3rd Quarter |
|
Year-to-Date |
North America |
|
|
67 |
% |
|
|
67 |
% |
Europe |
|
|
16 |
% |
|
|
17 |
% |
Asia-Pacific / Middle East |
|
|
13 |
% |
|
|
12 |
% |
Latin America |
|
|
4 |
% |
|
|
4 |
% |
|
|
|
|
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
|
|
|
|
The following table shows the percentage change in our volume by geographic zone for the three and
nine months ended September 30, 2007 compared to the corresponding periods in 2006:
|
|
|
|
|
|
|
|
|
|
|
2007 vs. 2006 |
|
|
% Change |
|
|
3rd Quarter |
|
Year-to-Date |
North America |
|
|
|
|
|
|
(1 |
%) |
Europe |
|
|
2 |
% |
|
|
5 |
% |
Asia-Pacific / Middle East |
|
|
17 |
% |
|
|
20 |
% |
Latin America |
|
|
1 |
% |
|
|
21 |
% |
Total |
|
|
2 |
% |
|
|
3 |
% |
In the first quarter of 2007, we made a minor change to improve the consistency of our reporting of
shipment volumes. Volume in our performance coatings product line, and to a much lesser extent,
our Noveon® consumer specialties product line, were reported previously on a dry basis,
or excluding the carrier fluid that is shipped with
the base performance material. We are now reporting all product lines on an as-shipped basis,
including carrier fluid that is blended with the base material.
Volume in North America was level and decreased 1% for the three and nine months ended September
30, 2007, respectively, with increases in our engineered polymers and Noveon consumer specialties
product lines more than offset by decreases in our performance coatings product line. The
increases in both periods in our Noveon consumer specialties product line were due to increased
customer demand in our surfactants business and increased customer demand in the personal care
market. Volume in our engineered polymers product line increased due to strong sales of
TempRite® engineered polymers products (TempRite) into industrial and fire sprinkler
applications offset by weaker sales into plumbing applications in the three-month period and
increased due to strong demand in
-36-
fire sprinkler, industrial and plumbing applications for the
nine-month period. Volume in our performance coatings product line decreased in both periods due to
reduced customer demand in textiles and inks applications.
Volume in Europe increased 2% and 5% for the three and nine months ended September 30, 2007,
respectively, with increases in our engineered polymers and Noveon consumer specialties product
lines more than offsetting decreases in our performance coatings product line. Higher customer
demand in TempRite, Estane® engineered polymers business (Estane), and sales into the
personal care and pharmaceutical markets more than offset reduced customer demand in paints and
coatings applications. In addition, the three-month comparative period was impacted unfavorably by
reduced customer demand.
Volume in Asia-Pacific increased 17% and 20% for the three and nine months ended September 30,
2007, respectively, with increases in all of our product lines in both periods. This increase was
due to strong customer demand in plumbing, industrial, paints and coatings, inks, film and sheet
and personal care applications. In addition, the nine-month comparative period was impacted
favorably by strong customer demand in textiles applications.
Volume in Latin America increased 1% and 21% for the three and nine months ended September 30,
2007, respectively. For the three-month period, volume increases in our performance coatings
product line were due to higher customer demand in paints and coatings and inks applications and
partially were offset by reduced customer demand in our engineered polymers product line, primarily
in plumbing applications. The volume increase in the nine-month period primarily was caused by
increased customer demand in plumbing, personal care, and paints and coatings applications.
Segment gross profit decreased 8% and increased less than 1% for the three and nine months ended
September 30, 2007, respectively, compared to the same periods in 2006. The decrease in the
three-month period primarily was due to higher average raw material
and manufacturing costs and competitive pricing pressures
experienced in our TempRite business. Segment gross profit increased slightly for the nine-month period due to an improvement in the
combination of price and product mix and an increase in volume, which partially was offset by
higher average raw material and manufacturing costs. Average raw material cost increased 6% for
both the three and nine months ended September 30, 2007, respectively, compared to the same periods
in 2006. Manufacturing costs increased for the three-month and nine-month comparative periods
primarily due to higher volume, an unfavorable currency impact and increased headcount.
Manufacturing costs on a per-unit-sold basis increased 8% and 6% for the three and nine months
ended September 30, 2007, respectively, compared to the same periods in 2006.
The gross profit percentages were 25.8% and 27.5% for the three and nine months ended September 30,
2007, respectively, compared to 29.1% in both corresponding prior-year periods. The decreases were
due to higher average raw material and manufacturing costs.
STAR expenses increased 6% and 10% for the three and nine months ended September 30, 2007,
respectively, compared to the same periods in 2006. The increases were due to higher base salaries
and benefits, increased headcount to support our growth strategy, an
unfavorable currency impact, higher incentive compensation expense
and the implementation of a common information systems platform.
Segment operating income for the three and nine months ended September 30, 2007 of $30.9 million
and $119.8 million, respectively, decreased 27% and 12% compared to the same periods in 2006 due to
the factors discussed above.
-37-
WORKING CAPITAL, LIQUIDITY AND CAPITAL RESOURCES
The following table summarizes the major components of cash flow:
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
September 30, |
|
|
2007 |
|
2006 |
Cash provided by (used for): |
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
406.5 |
|
|
$ |
245.1 |
|
Investing activities |
|
|
(125.7 |
) |
|
|
189.4 |
|
Financing activities |
|
|
(221.1 |
) |
|
|
(145.2 |
) |
Effect of exchange-rate changes on cash |
|
|
10.6 |
|
|
|
8.0 |
|
|
|
|
|
|
|
|
Net increase in cash and short-term
investments |
|
$ |
70.3 |
|
|
$ |
297.3 |
|
|
|
|
|
|
|
|
Operating Activities
The increase in cash provided by operating activities for the nine months ended September 30, 2007
compared to the same period in 2006 primarily related to an increase in net income and an
improvement in working capital levels. Specifically, we focused our efforts toward reducing
inventory levels and our accounts payable improved due to the timing of raw material purchases and
cash disbursements. In addition, the accounts payable we retained at the closing of the FIIS
divestiture had an unfavorable impact to operating cash flows of $27.0 million during the nine
months ended September 30, 2006. We also improved the timeliness of our collections, which
partially offset our increase in accounts receivable associated with higher revenues.
We manage our levels of inventories and accounts receivable on the basis of average days sales in
inventory and average days sales in receivables. We establish our target for days sales in
inventory with the goal of minimizing our investment in inventories while at the same time ensuring
adequate supply for our customers. We establish our target for accounts receivable by taking into
consideration the weighted average of our various terms of trade for each segment.
Investing Activities
In the first quarter of 2007, we used $15.7 million to acquire assets from Lockhart. For the nine
months ended September 30, 2006, we received cash proceeds from the sales of the FIIS and A&I
businesses. Our capital expenditures for the nine months ended September 30, 2007 were $121.6
million compared to $91.2 million for the same period in 2006. In 2007, we estimate annual capital
expenditures will be approximately $175.0 million to $180.0 million.
Financing Activities
Cash used for financing activities increased $75.9 million for the nine months ended September 30,
2007 compared to the same period in 2006. Cash used for financing activities of $221.1 million for
the nine months ended September 30, 2007 primarily consisted of
the repayment of 85.0 million
against our 250.0 million revolving credit agreement, which repaid our euro credit facility in
full, the repurchase of common shares and the payment of dividends, partially offset by proceeds
from the exercise of stock options. This compares to $145.2 million used
for
-38-
financing activities in the same period in 2006, which primarily consisted of the repayment of
long-term debt and payment of dividends, partially offset by proceeds from the exercise of stock
options.
On April 23, 2007, our board of directors authorized an enhanced share repurchase program that,
upon completion of repurchases under a previous repurchase program, permits us to repurchase up to
5.0 million of our common shares. We would expect that the timing of repurchases will depend on
market conditions and these will be balanced with other strategic
uses of our cash. Our current intention is to
repurchase up to $300.0 million of our shares through 2009.
Capitalization, Liquidity and Credit Facilities
At September 30, 2007, our total debt outstanding of $1,432.3 million consisted of 72% fixed-rate
debt and 28% variable-rate debt, including $400.0 million of fixed-rate debt that effectively has
been swapped to a variable rate. Our weighted-average interest rate as of September 30, 2007 was
approximately 6.0%.
Our net debt to capitalization ratio was 29.6% and 36.5% at September 30, 2007 and December 31,
2006, respectively. Net debt represents total short-term and long-term debt, excluding original
issue discounts and unrealized gains and losses on derivative instruments designated as fair-value
hedges of fixed-rate debt, reduced by cash and short-term investments. Capitalization is
calculated as shareholders equity plus net debt. Total debt as a percent of capitalization was
43.4% and 47.8% at September 30, 2007 and December 31, 2006, respectively.
Our ratio of current assets to current liabilities was 2.8 and 2.9 at September 30, 2007 and
December 31, 2006, respectively.
Our $350.0 million revolving U.S. credit facility, which matures in September 2011, allows us to
borrow at variable rates based upon the U.S. prime rate or LIBOR plus a specified credit spread.
At September 30, 2007, we had no outstanding borrowings under this agreement.
At September 30, 2007, two of our wholly owned, foreign subsidiaries had a 250.0 million
revolving credit facility that matures in September 2010. This credit agreement permits these
foreign subsidiaries to borrow at variable rates based on EURIBOR plus a specified credit spread.
At September 30, 2007, we had nothing outstanding under this agreement.
Our cash
and short-term investments balance of $646.0 million at September 30, 2007 will be used to fund ongoing operations,
pay down debt, pursue acquisitions and repurchase shares. On November 1, 2007, the company
completed the acquisition of the refrigeration lubricants business of
Croda for approximately $124.1 million. The acquisition was funded using a portion of the companys available cash.
Given the redemption premium on our long-term debt, it is unlikely that we will reduce debt
significantly before our next scheduled maturity in late 2008.
Contractual Cash Obligations
Our contractual cash obligations as of December 31, 2006 are contained in our annual report on Form
10-K/A for the year ended December 31, 2006. During the nine months ended September 30, 2007, our
non-cancelable purchase commitments decreased approximately $15.2 million to $162.8 million. Other
than the decrease in non-cancelable purchase commitments, we do not believe there have been any
significant changes since December 31, 2006 in our contractual cash obligations. The
non-cancelable purchase commitments by period at September 30, 2007 were $23.0 million, $122.2
million, $13.6 million and $4.0 million for the 2007, 2008-2009, 2010-2011 and 2012 and later
periods, respectively.
-39-
Our debt requires us to dedicate a portion of our cash flow to make interest and principal
payments, thereby reducing the availability of our cash flow for acquisitions or other purposes.
Nevertheless, we believe our future operating cash flows will be sufficient to cover our debt
repayments, capital expenditures, dividends, share repurchases and other obligations and that we
have untapped borrowing capacity that can provide us with additional financial resources. We
currently have a shelf registration statement filed with the Securities and Exchange Commission
(SEC) under which $359.8 million of debt securities, preferred shares or common shares may be
issued. As of September 30, 2007, we also maintained cash and short-term investment balances of
$646.0 million and had $350.0 million available under our revolving U.S. credit facility and
another 250.0 million available under our euro revolving credit facility. In addition, as of
September 30, 2007, we had $42.0 million of contingent obligations under standby letters of credit
issued in the ordinary course of business to financial institutions, customers and insurance
companies to secure short-term support for a variety of commercial transactions, insurance and
benefit programs.
NEW ACCOUNTING STANDARDS
Effective January 1, 2007, we adopted the provisions of Financial Accounting Standards Board (FASB)
Interpretation (FIN) No. 48 Accounting for Uncertainty in Income Taxes. FIN No. 48 prescribes a
recognition threshold and measurement attribute for the financial statement recognition and
measurement of tax positions taken or expected to be taken in tax returns. Under FIN No. 48, the
economic benefit associated with a tax position only will be recognized if it is more likely than
not that a tax position ultimately will be sustained. After this threshold is met, a tax position
is reported at the largest amount of benefit that is more likely than not to be ultimately
sustained. FIN No. 48 also provides guidance on derecognition, classification, interest and
penalties, accounting in interim periods and disclosure. Prior to January 1, 2007, we regularly
assessed positions with regard to tax exposures and recorded liabilities for uncertain income tax
positions in accordance with Statement of Financial Accounting Standards (SFAS) No. 5, Accounting
for Contingencies.
As a result of adopting FIN No. 48 on January 1, 2007, we recognized an $8.9 million reduction to
retained earnings and a $5.4 million increase to goodwill for pre-acquisition income tax
liabilities of Noveon International, Inc. (Noveon International). As of January 1, 2007, after
recording this FIN No. 48 adoption impact, we had gross unrecognized tax benefits of $57.8 million,
of which $38.8 million, if recognized, would affect the effective tax rate.
We recognize accrued interest and penalties related to unrecognized tax benefits as a component of
the income tax provision. As of January 1, 2007, the date of adoption, we had accrued interest of
$7.1 million. Penalties were immaterial to our consolidated financial statements.
We operate in numerous taxing jurisdictions and are subject to regular examinations by various U.S.
federal, state and foreign jurisdictions. Our income tax positions are based on research and
interpretations of the income tax laws and rulings in each of the jurisdictions in which we do
business. Due to the subjectivity of interpretations of laws and rulings in each jurisdiction, the
differences and interplay in tax laws between those jurisdictions and difficulty in estimating the
final resolution of complex tax audit matters, our estimates of income tax liabilities may differ
from actual payments or assessments.
It is reasonably possible that unrecognized tax benefits may decrease by up to $6.3 million within
12 months of September 30, 2007 primarily as a result of the settlement of foreign audits and the
closure of statutes of limitations.
With few exceptions, we are no longer subject to U.S. federal, state and local tax examinations for
years before 2001 and foreign jurisdiction examinations for years before 2000.
-40-
Effective with the adoption of FIN No. 48, the majority of the companys unrecognized tax benefits
are classified as noncurrent liabilities because payment of cash is not expected within one year.
Prior to the adoption of FIN No. 48, the company classified unrecognized tax benefits in accrued
expenses and other current liabilities.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities. This statement permits entities to make an irrevocable election to measure
many financial instruments and certain other items at fair value at specified election dates. The
fair value option may be applied instrument by instrument and must be applied to entire
instruments. Unrealized gains and losses on items for which the entity elects the fair value
option are reported in earnings. SFAS No. 159 is effective for fiscal years beginning after
November 15, 2007. Early adoption is permitted as of the beginning of the fiscal year that begins
on or before November 15, 2007, provided the entity also elects to apply the provisions of SFAS No.
157, Fair Value Measurements. Entities are not permitted to apply this statement retrospectively
to the fiscal years preceding the effective date unless the entity chooses early adoption. We
currently are evaluating the impact of this recently issued standard on our consolidated financial
statements.
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements. This statement defines
fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP and
expands disclosure about fair value measurements. SFAS No. 157 does not expand the use of fair
value measures in financial statements, but simplifies and codifies related guidance within U.S.
GAAP. SFAS No. 157 establishes a fair value hierarchy using observable market data as the highest
level and an entitys own fair value assumptions as the lowest level. SFAS No. 157 is effective
for fiscal years beginning after November 15, 2007 and interim periods within those years. SFAS
No. 157 requires adoption prospectively as of the beginning of the fiscal year in which this
statement is initially applied, with the exception of certain financial instruments in which
adoption is applied retrospectively as of the beginning of the fiscal year in which this statement
is initially applied. We currently are evaluating the impact of this recently issued standard on
our consolidated financial statements.
CAUTIONARY STATEMENTS FOR SAFE HARBOR PURPOSES
This Managements Discussion and Analysis of Financial Condition and Results of Operations contains
forward-looking statements within the meaning of the federal securities laws. As a general matter,
forward-looking statements are those focused upon future plans, objectives or performance as
opposed to historical items and include statements of anticipated events or trends and expectations
and beliefs relating to matters not historical in nature. Forward-looking statements are subject
to uncertainties and factors relating to our operations and business environment, all of which are
difficult to predict and many of which are beyond our control. These uncertainties and factors
could cause our actual results to differ materially from those matters expressed in or implied by
any forward-looking statements, although we believe our expectations reflected in those
forward-looking statements are based upon reasonable assumptions. For this purpose, any statements
contained herein that are not statements of historical fact should be deemed to be forward-looking
statements.
We believe that the following factors, among others, could affect our future performance and cause
our actual results to differ materially from those expressed or implied by forward-looking
statements made in this quarterly report:
|
|
|
The cost, availability and quality of raw materials, especially petroleum-based products. |
|
|
|
|
Our ability to sustain profitability of our products in a competitive environment. |
|
|
|
|
The demand for our products as influenced by factors such as the global economic
environment, longer-term technology developments and the success of our commercial development
programs. |
|
|
|
|
The risks of conducting business in foreign countries, including the effects of
fluctuations in currency exchange rates upon our consolidated results and political, social,
economic and regulatory factors. |
-41-
|
|
|
The extent to which we are successful in expanding our business in new and existing markets
and in identifying, understanding and managing the risks inherent in those markets. |
|
|
|
|
The effect of required principal and interest payments on our ability to fund capital
expenditures and acquisitions and to meet operating needs. |
|
|
|
|
Our ability to identify, complete and integrate acquisitions for profitable growth and
operating efficiencies. |
|
|
|
|
Our success at continuing to develop proprietary technology to meet or exceed new industry
performance standards and individual customer expectations. |
|
|
|
|
Our ability to implement a new common information systems platform primarily into our
Lubrizol Advanced Materials segment successfully, including the management of project costs,
its timely completion and realization of its benefits. |
|
|
|
|
Our ability to continue to reduce complexities and conversion costs and modify our cost
structure to maintain and enhance our competitiveness. |
|
|
|
|
Our success in retaining and growing the business that we have with our largest customers. |
|
|
|
|
The cost and availability of energy, especially natural gas and electricity. |
|
|
|
|
The effect of interest rate fluctuations on our net interest expense. |
|
|
|
|
The risk of transportation or weather-related disruptions to our Lubrizol Additives
production facilities located near the U.S. Gulf Coast. |
|
|
|
|
Significant changes in government regulations affecting environmental compliance. |
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We operate manufacturing and blending facilities, laboratories and offices around the world and
utilize fixed-rate and variable-rate debt to finance our global operations. As a result, we are
subject to business risks inherent in non-U.S. activities, including political and economic
uncertainties, import and export limitations and market risks related to changes in interest rates
and foreign currency exchange rates. We believe the political and economic risks related to our
foreign operations are mitigated due to the stability of the countries in which our largest foreign
operations are located.
In the normal course of business, we use derivative financial instruments including interest rate
and commodity hedges and forward foreign currency exchange contracts to manage our market risks.
Our objective in managing our exposure to changes in interest rates is to limit the impact of such
changes on our earnings and cash flow. Our objective in managing the exposure to changes in
foreign currency exchange rates is to reduce volatility on our earnings and cash flow associated
with such changes. Our principal currency exposures are the euro, the pound sterling, the Japanese
yen and certain Latin American currencies. Our objective in managing our exposure to changes in
commodity prices is to reduce the volatility on earnings of utility expense. We do not hold
derivatives for trading purposes.
We measure our market risk related to our holdings of financial instruments based on changes in
interest rates, foreign currency exchange rates and commodity prices utilizing a sensitivity
analysis. The sensitivity analysis measures the potential loss in fair value, cash flow and
earnings based on a hypothetical 10% change (increase and decrease) in interest, currency exchange
rates and commodity prices. We use current market rates on our debt and derivative portfolios to
perform the sensitivity analysis. Certain items such as lease contracts, insurance contracts and
obligations for pension and other postretirement benefits are not included in the analysis.
Our primary interest rate exposures relate to our cash and short-term investments, fixed-rate and
variable-rate debt and interest rate swaps. The calculation of potential loss in fair value is
based on an immediate change in the net present values of our interest rate-sensitive exposures
resulting from a 10% change in interest rates. The potential loss in cash
-42-
flow and income before
tax is based on the change in the net interest income/expense over a one-year period due to an
immediate 10% change in rates. A hypothetical 10% increase in interest rates would have had a
favorable impact and a hypothetical 10% decrease in interest rates would have had an unfavorable
impact on fair values of $34.7 million and $41.1 million at September 30, 2007 and December 31,
2006, respectively. In addition, a hypothetical 10% increase in interest rates would have had an
unfavorable impact and a hypothetical 10% decrease in interest rates would have had a favorable
impact on cash flows and income before tax of $0.6 million and $1.5 million for 2007 and 2006,
respectively, on an annualized basis.
Our primary currency exchange rate exposures are to foreign currency-denominated debt, intercompany
debt, cash and short-term investments and forward foreign currency exchange contracts. The
calculation of potential loss in fair value is based on an immediate change in the U.S. dollar
equivalent balances of our currency exposures due to a 10% shift in exchange rates. The potential
loss in cash flow and income before tax is based on the change in cash flow and income before tax
over a one-year period resulting from an immediate 10% change in currency exchange rates. A
hypothetical 10% increase in currency exchange rates would have had an unfavorable impact and a
hypothetical 10% decrease in currency exchange rates would have had a favorable impact on fair
values of $20.5 million and $3.5 million at September 30, 2007 and December 31, 2006, respectively.
Further, a hypothetical 10% increase in currency exchange rates would have had an unfavorable
impact and a hypothetical 10% decrease in currency exchange rates would have had a favorable impact
on annualized cash flows of $27.9 million and $20.9 million, respectively, and on annualized income
before tax of $4.1 million and $3.7 million in 2007 and 2006, respectively.
Our primary commodity hedge exposures relate to natural gas and electric utility expenses. The
calculation of potential loss in fair value is based on an immediate change in the U.S. dollar
equivalent balances of our commodity exposures due to a 10% shift in the underlying commodity
prices. The potential loss in cash flow and income before tax is based on the change in cash flow
and income before tax over a one-year period resulting from an immediate 10% change in commodity
prices. A hypothetical 10% increase in commodity prices would have had a favorable impact and a
hypothetical 10% decrease in commodity prices would have had an unfavorable impact on fair values
of $1.5 million and $1.3 million at September 30, 2007 and December 31, 2006, respectively, and on
annualized cash flows and income before tax of $1.5 million and $0.4 million in 2007 and 2006,
respectively.
Item 4. Controls and Procedures
In connection with the restatement discussed in the Explanatory Note to this
quarterly report on Form 10-Q and in Note 16 contained in the Notes to Financial Statements, we reevaluated our disclosure controls
and procedures, as such term is defined in Rule 13a-15(e) of the
Securities Exchange Act of 1934, under
the supervision and with the participation of our management, including our chief executive officer
and chief financial officer. Based on that
reevaluation, our chief executive officer and chief financial officer identified a material weakness
in our internal control over financial reporting for deficiencies at some international locations
due to insufficient requisite technical knowledge of accounting for postemployment employee benefit
plans in accordance with U.S. GAAP. Solely as a result of this
material weakness, we concluded
that our disclosure controls were not effective as of September 30, 2007.
As a result of this material weakness, we have taken steps to remediate the internal control
weakness. Specifically, we contracted a third-party benefits consultant to complete a detailed
benefits review at our wholly owned subsidiary that generated the majority of the reporting errors,
made inquiries and conducted reviews of other international
locations and enhanced our training on the application of U.S. GAAP
to postemployment employee benefit plans and
other matters at our non-U.S. subsidiaries and joint ventures. In
connection with this quarterly report on Form 10-Q,
under the direction of our chief executive officer and chief financial officer, we have evaluated
our disclosure controls and
-43-
procedures as currently in effect, including the remedial actions noted
above, and we have concluded that, as of the date of this filing, our disclosure controls and procedures are
effective.
Other than the enhancements to our internal control over financial reporting related to the
accounting for postemployment employee benefit plans that occurred during the third quarter of
2007, there were no other changes in our internal control over financial reporting during the
quarter ended September 30, 2007 that have affected materially, or reasonably likely to affect
materially, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
In the third quarter of 2007, we finalized the settlement with the Louisville (KY) Metro
Air-Pollution Control District relating to alleged violations of the air permit held by our
Louisville, Kentucky facility. We paid a penalty of approximately $0.1 million and have remaining obligations
through 2007 to update certain procedures and plans at the facility.
Item 1A. Risk Factors
There are
no material changes from risk factors as disclosed previously in our
annual report on Form 10-K/A for the
year ended December 31, 2006.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
(a) |
|
On July 2, 2007, we issued 419 common shares in a private placement transaction
exempt from registration under the Securities Act of 1933 pursuant to Section 4(2) of
that Act. We issued the common shares to one former officer under a deferred
compensation plan. |
|
|
|
|
On August 1, 2007, we issued 8,407 common shares in private placement transactions
exempt from registration under the Securities Act of 1933 pursuant to Section 4(2) of
that Act. We issued the common shares to two former directors under deferred
compensation plans. |
|
|
|
|
On September 4, 2007, we issued 15 common shares in a private placement transaction
exempt from registration under the Securities Act of 1933 pursuant to Section 4(2) of
that Act. We issued the common shares to one former officer under a deferred
compensation plan. |
|
|
|
|
On September 4, 2007, we issued 312 common shares in a private placement transaction
exempt from registration under the Securities Act of 1933 pursuant to Section 4(2) of
that Act. We issued the common shares to one former director under a deferred
compensation plan. |
-44-
|
(c) |
|
The following table provides information regarding our purchases of Lubrizol
common shares during the third quarter. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Number |
|
|
|
|
|
|
|
|
|
|
Total Number |
|
(or Approximate Dollar |
|
|
|
|
|
|
|
|
|
|
of Shares (or Units) |
|
Value) of Shares (or |
|
|
Total Number of |
|
Average Price |
|
Purchased as Part of |
|
Units) that May Yet be |
|
|
Shares (or Units) |
|
Paid per Share |
|
Publicly Announced |
|
Purchased Under the |
Period |
|
Purchased1 |
|
(or Unit) |
|
Plans or Programs2 |
|
Plans or Programs |
Month #1
(July 1, 2007 through
July 31, 2007) |
|
119 Shares |
|
$ |
64.55 |
|
|
N/A |
|
5,928,799 Shares |
Month #2
(August 1, 2007 through
August 31, 2007) |
|
467,000 Shares |
|
$ |
60.26 |
|
|
467,000 Shares |
|
5,461,799 Shares |
Month #3
(September 1, 2007
through
September 30, 2007) |
|
60,004 Shares |
|
$ |
63.38 |
|
|
60,000 Shares |
|
5,401,795 Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
527,123 Shares |
|
|
|
|
|
527,000 Shares |
|
5,401,795 Shares |
|
|
|
1 |
|
This column includes common shares (119 in July; 0 in August and 4 in
September) that we purchased pursuant to our deferred compensation plans whereby we
withhold shares upon a distribution to pay the withholding taxes on behalf of the
employee and pursuant to our stock incentive plan in which participants exchange already
owned shares to us to pay for the exercise price of an option or whereby we withhold
shares upon the exercise of an option to pay the withholding taxes on behalf of the
employee. |
|
2 |
|
This column represents common shares that we purchased at a cost of $31.9
million pursuant to a share repurchase program announced on June 23, 1997. On April 23,
2007, our board of directors authorized an enhanced share repurchase program that permits
the company to repurchase up to 5.0 million of its common shares upon completion of
repurchases under the previous share repurchase program. These shares may be repurchased
in the open market or through negotiated transactions. The program does not have an
expiration date. |
Item 6. Exhibits
|
10.1* |
|
The Lubrizol Corporation Executive Death Benefit Plan (as amended) |
|
|
10.2* |
|
Employee Agreement effective June 3, 2004, between Noveon, Inc. and Julian M.
Steinberg. |
|
|
31.1 |
|
Rule 13a-14(a) Certification of the Chief Executive Officer, as created by
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
31.2 |
|
Rule 13a-14(a) Certification of the Chief Financial Officer, as created by
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
32.1 |
|
Certification of the Chief Executive Officer and Chief Financial Officer of The
Lubrizol Corporation pursuant to 18 U.S.C. Section 1350, as created by Section 906 of
the Sarbanes-Oxley Act of 2002. |
|
|
* |
|
Indicates management contract or compensatory plan or arrangement. |
-45-
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
THE LUBRIZOL CORPORATION
|
|
|
|
|
|
|
|
|
|
/s/ W. Scott Emerick |
|
|
|
|
|
|
|
|
|
W. Scott Emerick |
|
|
|
|
Chief Accounting Officer and Duly Authorized |
|
|
|
|
Signatory of The Lubrizol Corporation |
|
|
|
|
|
|
|
Date: November 9, 2007 |
|
|
|
|
-46-